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Abstract 
Previous research has shown that the stress hormone corticosterone can increase 
depressive and anxiety-like behavior in rats as well as dampen the HPA response to a novel 
stressor (Kalynchuk et aI., 2004; Johnson et aI., 2006). Several studies have also shown that 
adolescence is a period of increased sensitivity to the negative effects of stressors (reviewed in 
McCormick et aI., 2010), which are often the result of exposure to corticosterone, and yet there is 
no research to date examining the effects of corticosterone administration during adolescence. 
The purpose of these experiments is to determine both the immediate and enduring effects of 
prolonged exposure to corticosterone in adolescence and adulthood on anxiety-like behavior, 
depressive behavior, and the HPA response. In Experiment 1 adolescent and adult rats were 
administered an injection of 40 mg/kg of corticosterone or vehicle daily for 16 days. Half of the 
rats were then tested on the elevated plus maze (EPM) one day after their last injection, and the 
following day were tested on the forced swim test (FST). After the FST, which is a stressor, 
blood samples were collected at three time points, and the plasma concentrations of 
corticosterone were determined using a radioimmunoassay. The remaining rats were left 
undisturbed for three weeks, and then underwent the same testing as the first group. 
Corticosterone treatment had little effect on anxiety-like and depressive behavior, but it did alter 
the HPA response to the FST. In those rats tested soon after the period of injections, 
corticosterone dampened the HPA response as compared to vehicle treated rats in both adolescent 
and adult treated rats. For the adolescent treated rats that were tested several weeks later, 
corticosterone treatment increased HPA response as compared to the vehicle treated rats, but the 
same was not true for the adult treated rats. It was hypothesized that the lack of behavioral 
effects of the corticosterone treatment may be the result of the vehicle injections inducing a stress 
response and thereby both groups would have similarly altered behavior. In Experiment 2 rats 
were administered corticosterone dissolved in their drinking water with 2.5% ethanol, or just the 
2.5% ethanol or plain water, to determine the effects of corticosterone treatment without a 
stressor present. The regular drinking water was replaced with treated water for 16 days either 
during adulthood or adolescence, and as before, rats were either tested in the FST one day after 
the water was removed or three weeks later. Again there was no effect of treatment on depressive 
behavior. Similar to what was observed in Experiment 1, corticosterone treatment dampened the 
HPA response to a stressor for the rats tested soon after the treatment period. However, in 
Experiment 2 there was no effect of treatment on HPA response in those rats tested several weeks 
after they were treated. These results indicate that corticosterone can have a lasting effect on the 
HPA when administered in adolescence by injections but not in drinking water, which is likely 
because of the different schedules of exposure and rates of absorption between the two 
administration methods. 
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Introduction 
The peak age for the onset of mental health disorders such as depression, anxiety 
disorders, schizophrenia and eating disorders like anorexia nervosa is 14 years old, during 
adolescence (reviewed in Giedd et aI., 2008). Depression and anxiety disorders have been linked 
to stress and stress related hormones (reviewed in Parker et aI., 2003). Adolescents have been 
shown to be more susceptible to the long term effects of stress than adults (reviewed in Lupien et 
aI., 2009; McCormick et aI., 2010). Increased susceptibility to stress during adolescence is likely 
responsible for the young age of onset for stress related mood disorders. However there is scant 
research available that addresses the question of why adolescents are more susceptible to the 
long term effects of stress, and there is no research to date that directly studies the effects of 
exposure to stress hormones during adolescence. The experiments described in this thesis will 
address the immediate and long term effects of administering corticosterone, the major stress 
hormone in that rat, during both adolescence and adulthood on anxiety-like behavior, depressive 
behavior, and the stress response in the rat. Animal models are necessary in the study of stress 
because they allow a level of experimental control that is not possible ethically in studies 
involving people. Experiments using animal models allow us to interpret correlation studies with 
people more accurately, and provide the base for informed hypotheses relating to human 
disorders. A general overview of the stress system, the hypothalamic-pituitary-adrenal axis, of 
the rat will be given. Animal models of anxiety and depressive behavior will be discussed as well 
as the effects of stress on these behaviors. This will be followed by a discussion of adolescence, 
and the ways in which adolescent rats differ from adult rats in terms of their stress response. 
How stress and corticosterone, one of the key hormones of the stress response, can affect anxiety 
and depressive behaviors in adolescents will then be discussed. The current experiment will 
determine if exogenous corticosterone administered during adolescence will have a lasting effect 
_ on emotional behaviors and the stress response. Corticosterone should increase depression and 
anxiety-like behavior, and that corticosterone will alter the stress response. When the 
corticosterone is presented during adolescence, a time of ongoing brain development, these 
effects should be long lasting. 
Hypothalamic-Pituitary-Adrenal Axis of the Rat 
One of the functions of the hypothalamic-pituitary-adrenal (HPA) axis is to respond to 
aversive and potentially harmful situations to maintain homeostasis (reviewed in Herman & 
Cullinan, 1997). A stressor will activate the paraventricular nucleus of the hypothalamus where 
neurons will release corticotropin releasing hormone, which will travel to the pituitary gland. The 
pituitary will then release adrenocorticotropic hormone into the blood stream, which will travel 
to the adrenal gland. The adrenal cortex produces and releases corticosterone when it detects an 
adrenocorticotropic hormone. The amount of corticosterone present in the blood stream is 
common measure of the intensity of a stressor. For example, when exposed to electric shock, 
increased shock intensity induced a larger release of corticosterone resulting in higher blood 
plasma concentrations of corticosterone (Cordero et aI., 1998). The HPA can be activated by 
several different stressors such as restraint, isolation, tail shock, swim, elevated platform, 
predator odor, direct predator exposure, social instability or a combination of several of these and 
possibly others referred to as chronic unpredictable stress. Each of these stressors triggers 
corticosterone release, which activates receptors in several brain areas for a variety of effects. 
There are two types of receptors for corticosterone present in the rat brain: glucocorticoid 
receptors (GRs) and mineralocorticoid receptors (MRs). MRs have a ten fold higher affinity for 
corticosterone than GRs do. Therefore at low concentrations of corticosterone the majority of the 
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MRs (89.5%) at morning trough when plasma corticosterone concentrations were 1.4 Ilg per 100 
- mL, will be occupied but not many GRs (15%) (Reul & de Kloet, 1985; Spencer et aI., 1990). At 
higher concentrations of corticosterone, such as those present after experiencing a stressor, GRs 
will become occupied in addition to MRs (Reul & de Kloet, 1985). For this reason MR activation 
is associated generally with basal levels of corticosterone and GR activation is associated 
generally with the stress response. GRs are found both in the cytosol and in the nuclear envelope, 
and when corticosterone is bound the receptor will relocate to the nucleus and bind to DNA 
(Spiga & Lightman, 2009). Activated GR will increase transcription in a dose dependent manner, 
and following a specific time line (Spiga & Lightman, 2009; Sarabdjitsingh et aI., 2009). Both 
MRs and GRs are found in high concentrations in the hypothalamus, hippocampus, amygdala, 
and medial prefrontal cortex (reviewed in de Kloet et aI., 1998). 
When high levels of corticosterone activate GRs, the hypothalamus will be inhibited 
resulting in reduced release of adrenocorticotropic hormone, which in tum prevents further 
release and production of corticosterone (reviewed in de Kloet et aI., 1998). This process is 
known as negative feedback, and it limits the duration and magnitude of corticosterone release 
(reviewed in Herrman et aI., 2009). One important site of negative feedback is the hippocampus, 
and when there is a large quantity ofGRs in the hippocampus the HPA is tightly controlled, and 
the reverse is true as well (reviewed in de Kloet et aI., 1998). Repeated exposure to 
corticosterone can damage the hippocampus (Woolley et aI., 1990; Watanabe et aI., 1992; Galea 
et aI., 1997; Magarinos et aI., 1998), which would likely reduce its control of the HPA. 
In addition to negative feedback, another mechanism for preventing excessive exposure 
to corticosterone is habituation. Habituation refers to a rats' ability to attenuate the release of 
corticosterone to a stressor that is presented repeatedly. This effect is stressor specific in that a rat 
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that has habituated to one stressor, for example intermittent cold presented for seven days, would 
- show decreased corticosterone release in response to cold but not in response to a novel stressor, 
such as restraint (Bhatnagar & Dallman, 1998). Habituation depends on the predictability of the 
stressor, and therefore it is context specific (Grissom et aI., 2007). Blocking both MRs and GRs, 
or MRs alone, can impair habituation, which indicates that receptors play an important role in 
habituation (Cole et aI., 2000). Although stressors will activate the HPA causing corticosterone 
release there are several mechanisms in place to prevent extensive exposure to corticosterone 
because corticosterone can disrupt emotional processing giving rise to changes in anxiety and 
depression-like behaviors. 
Stress, Corticosterone, and Anxiety 
Anxiety and fear share several causes, behaviors, and related brain structures, but anxiety 
can be distinguished from fear in several ways. Anxiety is a prolonged state of apprehension, 
whereas fear is a brief reaction that dissipates with the removal of the fearful stimuli. Anxiety is 
often elicited by a distant or potential threat, but fear is cued by an immediate clear threat 
(reviewed in Davis et aI., 201 Ob). When a fearful stimulus is present the basolateral nucleus of 
the amygdala signals the central nucleus of the amygdala, which in tum signals the 
hypothalamus and the brainstem to produce an initial fear response. When that stimulus remains 
present for a prolonged period of time, the central nucleus of the amygdala releases corticotropin 
releasing hormone to the bed nucleus of the stria terminalis, which creates an anxious reaction. 
At the same time inhibitory feedback within the amygdaloid nuclei terminates the fear response 
allowing for the transition from specific fear to generalized anxiety (reviewed in Davis et aI., 
2010b). Increased dendritic arborization in the amygdala has been linked to increased anxiety 
(Mitra & Sapolsky, 2008). Anxiety behaviors are both produced and mediated by the amygdaloid 
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nuclei, and therefore altered levels of anxiety may be indicative of disrupted processing or 
damage to the amygdaloid nuclei. 
A very common and well validated measure of anxiety in rodents is the elevated plus 
maze (EPM), first described by Pellow et al. (1985) (Wall & Messier, 2001), and the review of 
stressor and corticosterone effects on anxiety will be limited to studies that have used this 
measure. The EPM relies on the propensity of rodents to explore novel territory and their fear of 
open and elevated areas. The EPM consists of four arms elevated off the ground. Two arms are 
closed, with tall walls surrounding the edges, and two are open with no walls on the edges. The 
time spent in an open arm indicates the level of anxiety; more time would signify a less anxious 
animal. Rats will inherently spend more time in the closed arms than the open arms, but the 
amount of time spent in the open arm can be increased or decreased with anxiolytic and 
anxiogenic drugs respectively (Pellow et aI., 1985). Rats show increased plasma corticosterone 
concentrations when confined to the open arm, which is evidence that the open arm is aversive or 
stressful (Pellow et aI., 1985; Avital & Richter-Levin, 2005; Tsoory & Richter-Levin, 2005; 
Tsoory et a12007; Toth et a12008; McCormick et a12008; Zamudio et aI2009). 
One study using factor analysis described three main behavioral factors measured by the 
EPM, anxiety, risk assessment (which is also referred to as decision making) and activity 
(Doremus et aI., 2006). However, comparisons across factor analysis studies and other studies 
show that the factor of activity is ambiguous (rev in Wall & Messier, 2001). The behavioral 
measure that best describes activity in the EPM is not agreed upon, and whereas some use total 
arm entries as the measure of activity and others use closed entries, both of these variables load 
on the factor of anxiety in addition to the factor of activity (rev in Wall & Messier, 2001). There 
is no measure of activity on the EPM that is not influenced by anxiety to some degree. However, 
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closed entries are less influenced by anxiety than total entries because the measure of total 
. entries includes the entries into the open arm, which is a direct measure of anxiety. Whereas 
some factor analyses have shown that a factor of risk assessment should be included in the 
measures of behavior in the EPM (e.g. Doremus et aI., 2006), others argue that the variables that 
measure risk assessment are merely identifying elements of other constructs (Wall & Messier, 
2001). Although anxiety is the factor that all analyses agree upon, activity and risk assessment 
are less concurrent factors for the EPM. 
The majority of the literature shows that stress, both chronic and acute, increases anxiety 
as measured by the EPM. Studies have reported increased anxiety in the EPM in rats 24 hours 
after, four hours after, or immediately after one session of restraint (Calvo et aI., 2001; Lunga & 
Herbert, 2004; Gameiro et aI., 2006). When tested immediately following exposure to a 
compartment that had previously been paired with shock, rats showed increased anxiety on the 
EPM compared to control rats not exposed to the compartment (Gameiro et aI., 2006). Rats 
exposed to a predator odor (used cat litter), showed increased anxiety on the EPM (Tsoory et aI., 
2007). Acute stress can increase anxiety in the EPM across a range of time intervals between the 
stressor and the test. 
Several studies have examined the effects of chronic exposures to stress on anxiety, and 
predominantly report the same general effect of chronic stress on anxiety as for acute stress. 
Chronic restraint of various durations, six hours a day for one week (Bowman et aI., 2009), one 
hour daily for three or five days (Gameiro et aI., 2006), or two hours a day for 10 days (Vyas et 
aI., 2004) enhanced anxiety on the EPM. Restraint for one hour a day, five days a week, for 50 
days also increased anxiety (Nos chang et aI., 2009). Chronic unpredictable stress, a paradigm 
that involves changing the type of stressor from day to day to prevent habituation, increased 
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anxiety when the procedure continued for either two or four weeks (Bondi et aI., 2008; Pego et 
_ aI., 2008). These studies show that stress can increase anxiety as measured by the EPM. 
In contrast to the above studies finding a relationship between stress and heightened anxiety, 
some studies have reported various stressors to decrease anxiety or have no effect on anxiety in 
the EPM. Mice tested the day after exposed once to a cat showed decreased anxiety on the EPM 
compared to controls in one study (Adamec et aI., 2006), and no change in anxiety but increased 
risk assessment compared to controls in another study (Adamec et aI., 2004). However, other 
studies have found that predator odor mayor may not produce an effect on behavior depending 
on the particular cat used as a stimulus (Munoz-Abellan et aI., 2009; Munoz-Abellan et aI., 
2010). Therefore it is impossible to determine whether the behavior was unaffected by the 
stressor or if the particular cat used in this study was an ineffective stressor. Chronic 
unpredictable stress for a duration of one week produced a decrease in anxiety compared to 
unstressed controls (Kompagne et aI., 2008) and another study found no effect of chronic 
unpredictable stress presented for either one, seven or 14 days, on behavior in the EPM when 
compared to untreated controls (Matusewich et aI., 2007). These discrepancies might be caused 
by the duration of the stressor, because as noted above, unpredictable stress increased anxiety 
when it lasted for two or four weeks (Bondi et aI., 2008; Pego et aI., 2008). Furthermore, 
unpredictable stress models are difficult to compare to other studies because the stressors are not 
constant, and in fact the schedule of stressors and variety of stressors used changes from study to 
study. The wide variety in these procedures makes them difficult to compare one to another or 
with studies using the same stressor repeatedly. Thus, although there are examples of stress 
exposures decreasing anxiety, they are much less prevalent than studies that show stressors to 
increase anxiety. 
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Exogenous administrations of corticosterone generally mimic the effects of stressors on 
_ anxiety. Daily injections of 25 mg/kg of corticosterone to rats for 28 days increased anxiety on 
the EPM (Pego et aI., 2008), whereas administration of a GR antagonist to rats decreased anxiety 
on the EPM (Korte et aI., 1995), which confirms the anxiogenic properties of corticosterone. 
Removing the adrenal gland, the main source of endogenous corticosterone, abolishes the 
increase in anxiety caused by stress, and corticosterone replacement or treatment with GR or MR 
agonists will reinstate it (Calvo et aI., 2001). Treatment with metyrapone, a drug that prevents the 
synthesis of corticosterone, can also extinguish the increase in anxiety caused by stress, and 
treatment with the GR agonist, dexamethasone, will reinstate it (Calvo et aI., 2001). These 
studies indicate that the stress-induced increase in anxiety can be attributed to the release of 
corticosterone associated with stress. 
Several studies suggest that the amygdala is the locus of action for corticosterone's 
anxiogenic effects. One systemic injection of 10 mg/kg corticosterone increased anxiety in rats 
compared to vehicle injected controls, and the increased anxiety coincided with increased 
arborization in the basolateral amygdala (Mitra & Sapolsky, 2008). Exposure to stressors also 
increases spine density and enhances dendritic arborization in the basolateral nucleus of the 
amygdala (Mitra et aI., 2005; Vyas et aI., 2002). Anxiety in the EPM is increased when 
corticosterone is directly applied to the central nucleus of the amygdala (Shepard et aI., 2000). 
These studies indicate that the amygdala is the region responsible for the effect of stress and 
corticosterone on anxiety. 
The effect of stress on anxiety appears to be a lasting effect. Increased anxiety resulting 
from stress can still be observed after a 21 day recovery period, though to a lesser extent than 
that in rats tested immediately following the stressor (Vyas et aI., 2004). When corticosterone (50 
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~g/mL) was given to rats in their drinking water for 14 days followed by six days of a weaning 
-procedure whereby the dose was decreased incrementally, no effect was observed on EPM when 
tested either two weeks or one month after corticosterone treatment (Gourley & Taylor, 2009). 
One injection of 10 mg/kg of corticosterone, but not 10 daily injections, increased anxiety in the 
EPM when tested 12.days later (Mitra & Sapolsky, 2008). However, the chronic group was tested 
two days after the administration of corticosterone instead of 12 days later. It remains unclear 
whether the differences in results reported in these studies results from different durations of 
administration, or doses, or other differences between these procedures. More investigation into 
the long term effects of stress and corticosterone is necessary to clarify the point. 
Forced Swim Test: A Measure of Depressive Behavior 
Like increased anxiety levels, another indication of disrupted or altered emotional 
regulation is increased depressive behavior. Depression is a disorder with symptoms including 
feelings of sadness and helplessness, low self esteem, anhedonia, a lack of energy, insomnia, 
poor concentration, and an overall lack of positive emotions. Absence of happiness is a more 
consistent symptom of depression than increased sadness (Peeters et aI., 2003). Additionally 
most patients with anxiety disorders have one or more depressive disorders, and patients with 
both disorders have increased severity of their principle disorder (Davis et aI., 2010a). One of 
the first theories describing the underlying mechanism for depression is the monoamine theory, 
which states that depression is derived from to an imbalance in the neurotransmitter serotonin. 
One common class of antidepressants is selective serotonin re-uptake inhibitors, which prevent 
serotonin from being reabsorbed into the cell allowing it to remain in the synaptic cleft longer. A 
second common class of antidepressants is monoamine oxidase inhibitors, which inhibit the 
enzyme that decomposes serotonin, which also allows serotonin to remain in the synaptic cleft 
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longer. A newer theory points to the observation that depressed patients show evidence of a more 
active HPA axis such as increased plasma levels of cortisol, the human correlate of corticosterone 
(reviewed in Parker et aI., 2003). Both of the aforementioned classes of antidepressants in 
addition to altering serotonin levels will also normalize a patients' cortisol levels (reviewed in 
Parker et aI., 2003). The onset of depression is often preceded by an increase in stress or a 
particularly stressful event, and stress can exacerbate the symptoms of depression (reviewed in 
Parker et aI., 2003). Depression is also linked with decreased hippocampal volume, decreased 
prefrontal cortex volume, and altered amygdala volume, in that the nuclei of the amygdala are 
larger soon after the onset of depression but decrease with the progression of the disorder 
(reviewed in Sterner & Kalynchuk, 2010). It is possible that these structural changes are results 
of a more active HPA, but because the hippocampus plays a role in HPA axis regulation it is also 
possible that having a smaller hippocampus to begin with causes a more active HPA axis. Further 
research is required to determine which of these characteristics of depression might contribute to 
the mechanism for the disorder. 
Animal models can provide unique insight into the mechanisms behind disorders like 
depression. The forced swim test (FST) is a well validated measure of depressive behavior in the 
rodent. Although there are other tests of depressive behavior, this paper will only discuss the FST 
because of its reliability and widespread usage as a measure. Originally described by Porsolt and 
colleagues (1977), the test consists of a tall cylindrical tank filled with enough water such that 
the rat cannot stand on the bottom. The test consists of two sessions, a training session in which 
the animal is put in the tank for 15 to 20 minutes, and a second session 24 h later in which the rat 
is placed in the tank again for five minutes. The purpose of the first session is to induce 
depressive-like behavior by providing the animal with an inescapable stressor, water. During the 
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second session the amount of time the rat spent floating or moving just enough to keep its head 
_ above water, a behavior labeled immobility, was considered an index of depressive behavior. 
Spending more time immobile and becoming immobile sooner is indicative of a higher level of 
depression like behavior, and several studies have shown that a wide variety of antidepressants 
will decrease immobility when administered between the two sessions (Porsolt et aI., 1977; 
Armario et aI., 1988; Detke et aI., 1995; Tejani-Butt et aI., 2003; Pechnick et aI., 2008). Other 
factors that have been shown to decrease immobility include electroconvulsive shock, REM 
sleep deprivation, and environmental enrichment (Porsolt et aI., 1978). Later studies began to 
measure time spent actively swimming around the tank, time spent climbing the sides of the tank 
and time spent immobile separately. 
Whereas every class of antidepressant has been shown to decrease immobility on the 
FST, swimming and climbing represent distinct forms of non-depressive behavior, and they are 
differentially affected by separate classes of antidepressants (Porsolt et aI., 1977; Armario et aI., 
1988; Tejani-Butt et aI., 2003; Pechnick et aI., 2008; Detke et aI., 1995). Serotonin re-uptake 
inhibitors will increase the amount of time spent swimming whereas drugs related to 
norepinephrine will increase the amount of climbing, and both subsequently decrease the amount 
of time spent immobile (Detke et aI., 1995). Another study later replicated the norepinephrine-
related drug-induced increase in climbing in both adult (postnatal day 112) and young (postnatal 
day 30) rats (Pechnick et aI., 2008). A further study replicated the finding that serotonin related 
drugs increased swimming in young rats, postnatal day 21 (Reed et aI., 2008). Another study 
reported that reducing serotonin signaling in mice through the use of antisense mRNA for the 
serotonin 2A receptor resulted in increased time spent immobile in the FST compared to control 
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mice (Sibille et aI., 1997). These studies show that climbing and swimming behaviors in the 
- FST are tied to different neurotransmitter systems. 
Several types of chronic stressor procedures have been found to increase immobility in 
the FST. Restraint for two hours a day for one day, but not three or seven days, increased 
immobility during the first session of the FST, and seven days of restraint but not three or one 
days of restraint increased immobility on the second session of the FST (Cancela et aI., 1991). 
Chronic unpredictable stress of various durations and using a variety of stressors increased 
immobility on the first session of the FST (Echandia et aI., 1988; Molina et aI., 1994; Kompagne 
et aI., 2004). Several of these studies also show that antidepressants can ameliorate the effects of 
stress on behavior in the FST when they are given either after the stressor or directly before 
testing (Cancela et aI., 1991; Molina et aI., 1994). These studies demonstrate that stress can 
induce a depression-like state in rats as observed in the FST. 
Studies of the effects of acute stressors on behavior in the FST have less consistent 
findings than do those of the effects of repeated stressors. Both acute restraint and periodic tail 
shocks for one hour immediately prior to testing decreased immobility in a single session of the 
FST, but no effect on immobility was observed after loud noise stress or when a stressor was 
administered 24 hours before the test session (Armario et aI., 1991). In contrast, another study 
found no effect of two hours of periodic tail shocks on a single session of the FST, but in this 
study an anxiety test, the hole and board test, was performed between the shock and the FST, 
which may have affected the outcome of the FST (Pol et aI., 1992). The same study found that 
two hours of restraint increased immobility, and previous chronic exposure to immobilization 
exacerbated this effect (Pol et aI., 1992). Yet another study showed that resident intruder stress 
increased immobility in a single session of the FST when tested 24 hours later, but there was no 
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effect of six periodic foot shocks (Kavushansky et aI., 2009). Potentially the reason for these 
- discrepancies in the FST in relation to acute stressors is that the levels of circulating stress 
hormones have been dissociated from behavior on the task. Behavior during the FST has been 
shown to be the same for rats with different levels of circulating hormones (Walker et aI., 1995; 
Johnson et aI., 2006). Therefore the mechanisms underlying the behavioral effects of stress are 
more complicated than a direct response to hormone levels and less likely to be observed after an 
acute treatment. Additionally the length of time between the stress exposure and the test may 
have an effect on the outcome. More research is required to adequately explain the effects of 
acute stress on the FST. 
Unlike acute stress, chronic stress consistently is found to increase depressive behavior in 
the FST (Echandia et aI., 1988; Cancela et a., 1991; Molina et aI., 1994; Kompagne et aI., 2004; 
Maniam & Morris, 2010). Like other effects of chronic stress, this is likely the result of 
prolonged exposure to corticosterone. Chronic injections of 40 mg/kg of corticosterone for 21 
days increased immobility in a single session of the FST for both males and females (Kalynchuk 
et aI., 2004; Gregus et aI., 2005; Johnson et aI., 2006). Another study found that 19 days of 40 
mg/kg of corticosterone via subcutaneous injection was sufficient to decrease immobility (Lee et 
aI., 2009). The effect of corticosterone on immobility in the FST is dose dependent, and is 
observed using 40 mg/kg, but not 20 or 10 mg/kg of corticosterone (Johnson et aI., 2006). 
Further, an acute dose of 10,20, or 40 mg/kg had no effect on a single session of the FST when 
tested 24 hours after the injection (Johnson et aI., 2006). The 21 days of 40 mg/kg corticosterone 
injections produced an increase in immobility but 21 days of six hours of restraint did not affect 
immobility (Gregus et aI., 2005). The lack of a stress effect here may be caused by habituation to 
the stressor, which would result in lower levels of circulating corticosterone, because 
13 
corticosterone injections produced the expected effect. The effects of corticosterone in the FST 
_ may be long lasting. A study that provided mice with 50 Jlg/mL corticosterone in the drinking 
water for 14 days with a six day weaning procedure (whereby the dose was incrementally 
decreased) found increased immobility in the FST two weeks later (Gourley & Taylor, 2009). 
The duration of this effect may be the result of the unique schedule and dose, but it might be the 
case that the effect of corticosterone on depressive behavior is long lasting. Further research is 
required to determine if the effects of corticosterone on the FST are consistently long lasting. 
Wistar-Kyoto rats have a higher basal level of corticosterone compared to Wi star or 
Sprague-Dawley rats, and Wistar-Kyoto rats spend more time immobile than Wi star or Sprague-
Dawley rats in a single session of the FST (Tejani-Butt et aI., 2003). A low zinc diet for two 
weeks increases corticosterone response to a stressor and also increased immobility in a single 
session of the FST (Watanabe et aI., 2010). Because these studies show that enhanced 
corticosterone levels coincide with increased immobility on the FST, they also support the idea 
that the stress-induced increase in immobility on the FST is related to higher exposures to 
corticosterone. 
There is much evidence that stress and high levels of corticosterone increase anxiety-like 
and depressive behavior. However, thus far all of the studies discussed only involved adults. 
Many anxiety and depression-related disorders are first manifested during adolescence, and 
therefore the role of stressors experienced during adolescence, a time of increased brain 
development, requires greater investigation. I will review the basics of the rat model of 
adolescence, and then I will discuss the research relating to the effects of stress on depressive and 
anxiety-like behavior in adolescence that is available thus far. 
Adolescence 
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Adolescence is a period of ongoing development in the brain and of marked differences 
- in behavior as compared to younger and older individuals (reviewed in Spear, 2000b). As for 
people, there is no precise onset or offset of adolescence in the rat. There are three stages 
considered to represent adolescence in the rat. There is a prepubescent early stage from postnatal 
day 21 through 34 (rats are usually weaned at day 21), a mid adolescent period from day 34 to 
46, and a late adolescent stage from day 47 to 60 (reviewed in McCormick & Mathews, 2007). 
Rats older than day 60 are commonly agreed to be adults because adult-like sexual behavior has 
developed and rats are physically mature at this age (reviewed in.McCormick & Mathews, 
2007). Adolescence includes sexual maturation, but that is only one aspect of the development 
occurring in adolescence. The prefrontal cortex, hippocampus, and amygdala all undergo 
development during adolescence (reviewed in Lupien et aI., 2009). The HPA axis also is 
continuing to develop in adolescence (reviewed in McCormick & Mathews, 2007). Adolescence 
is also a time of altered behavior, and behaviors such as social play and risk taking are increased 
during this time period compared to both older and younger rats (reviewed in Spear, 2000a). 
HPA Activation During Adolescence 
Adolescents differ from adults both behaviorally and in their physiological response to 
stressors, depending on the type and duration of the stressor. Several studies'have shown 
adolescent rats to have more prolonged release of corticosterone in response to 30 minutes of 
restraint (Romeo et aI., 2004a; Romeo et aI., 2004b; Romeo et aI., 2006; McCormick et aI., 2008; 
Doremus et aI., 2009b; Goldman et aI., 1973; Vazquez & Akil, 1993; Novak et aI., 2007). 
Although adolescents show an increased HPA response to a stressor, they will habituate with 
repeated presentations, like adults do. One study found that the release of adrenocorticotropic 
hormone was higher in adolescents only on the first of three days of restraint for three hours a 
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day, and the release of corticosterone was higher only on the second day (Gomez et aI., 2002). 
- After seven days of restraint for 30 minutes adolescents had a higher corticosterone and 
adrenocorticotropic hormone response to the same stressor, restraint, which would indicate less 
habituation than adults (Romeo et aI., 2006). Not all stressors have the same effect during 
adolescence. A social stressor, changing cage partners, in combination with isolation induced a 
greater stress response at day 30 than isolation alone, and when presented for 16 days, the social 
stressor showed less habituation of the corticosterone response compared to isolation alone 
(McCormick et aI., 2007). Repeated stressors presented during adolescence clearly have an 
effect on the HPA, but whether that effect is similar to adults depends on the type and schedule of 
the stressor. 
Several studies have looked at the lasting effects of stress during adolescence on the HPA 
axis. The type of stressor, timing of presentation and time elapsed between the last stress 
presentation and testing can all affect the outcome of the experiment. There are several studies 
showing increased HPA reactivity lasting into adulthood in rodents that experienced stress during 
adolescence. Isolation housing for three weeks during adolescence prolonged the corticosterone 
release in response to a stressor when tested two weeks following isolation (Lukkes et aI., 2009). 
Restraint for 10 days at one hour a day during adolescence, increased basal corticosterone levels 
measured two days after the stressor (Lepsch et aI., 2005). One experiment presented restraint, 
forced swim, and ether stress, once each during adolescence, which increased basal 
corticosterone levels, an effect still observed seven days after the last stressor (Uys et aI, 2006a; 
Uys et aI., 2006b). Chronic unpredictable stress presented for four weeks during adolescence 
increased basal corticosterone when tested 103 days after the stressor (Pohl et aI., 2007). 
Changing rats' cage partners for 50 days during adolescence increased arginine vasopressin 
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mRNA levels in the paraventricular nucleus of the hypothalamus, but not adrenocorticotropic 
_ hormone or corticotropin releasing hormone mRNA in the paraventricular nucleus of the 
hypothalamus (Sterlemann et aI., 2008). These studies show that several different types of 
stressors with various schedules when presented during adolescence can increase HPA reactivity 
long after the original stressor was experienced. 
Nevertheless, there are several studies that show decreased HPA activation in rats that 
have experienced stress during adolescence. Chronic unpredictable stress presented for 42 days 
during adolescence induced a blunted adrenocorticotropic hormone release to either corticotropin 
releasing hormone injection or three minutes of ether exposure (Goliszek et aI., 1996). 
Alternating cage partners for 50 days during adolescence decreased basal levels of ACTH when 
measured in the morning but not in the afternoon (Schmidt et aI., 2007). Chronic unpredictable 
stress of a mild nature presented for four weeks during adolescence decreased basal levels of 
corticosterone when measured in the evening two weeks later (Toth et aI., 2008). Forced swim, 
restraint and ether stress presented once each during adolescence decreased the number of cells 
containing GRs in the dentate gyrus of the hippocampus (Uys et aI., 2006b). Changing cage 
partners for 50 days during adolescence decreased the levels of MR and GR mRNA found in the 
CAl region but not the dentate gyrus of the hippocampus (Sterlemann et aI. 2008). These studies 
show that stress during adolescence can cause a dampened HPA response to stress, lower 
baseline levels of HPA activity, and decreased levels of receptors to respond to corticosterone. 
However, these effects are potentially compensatory responses to heightened levels of 
corticosterone from the stressors. For example lowered basal levels of corticosterone may be the 
result of increased negative feedback induced by the repeated stressor presentations. Negative 
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feedback can reduce the production of corticosterone in the adrena1s, and thus the rats would 
_ display lower basa11eve1s. 
There is a set of studies that found no lasting effect of stress experienced during 
adolescence on the HPA axis. Three sessions of foot shock that were two days apart during 
adolescence had no effect on corticosterone response to foot shock when tested two months later 
(Overmier & Murison, 1991). This study presents a problem because the stress used to test the 
HPA was the same as the stress originally presented, and therefore it is unclear whether there 
would have been an effect on the HPA if tested with a heterotypic stressor. Chronic isolation for 
16 days paired with changing cage partners (McCormick et aI., 2005, Mathews et aI., 2008; 
McCormick et aI., 2008), chronic unpredictable stress for 11 days (Mas10va et aI., 2002), 
exposure to predator odor for 25 minutes a day for three days (Toledo-Rodriguez & Sandi, 
2007), exposure to predator odor on five separate occasions for 30 minutes (Wright et aI., 2008), 
had no effect on corticosterone response to a new stressor when tested in adulthood. Sleep 
deprivation that prevented rapid eye movement (REM) sleep for one week during adolescence 
had no lasting effect on basa11eve1s of corticosterone (Shaffery et aI., 2006). Taken together, 
these studies show that not all types and schedules of stressors have a lasting effect on HPA 
activity. It is possible that the difference between these groups of studies lies in the level of 
corticosterone released over the course of the stressor presentation. Several of the studies that do 
observe long term effects include stressor presentations of much longer duration than those that 
do not. Adolescent rats have been shown to habituate their corticosterone release over the course 
of 16 days of chronic isolation and to a lesser extent when that isolation is paired with changing 
the cage partner upon return to the home cage (McCormick et aI., 2007). Therefore different 
levels of exposure to corticosterone may also be the reason for the discrepancy between studies 
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in lasting effects on the HPA. Further research is required to determine the precise"role of 
_ corticosterone exposure during adolescence on the ongoing development of the HPA axis. 
Adolescence, Stressors, Anxiety and Depressive Behavior 
Stressors, both acute and repeated, can also affect the behavior of adolescents. There is 
evidence that stress during adolescence can increase anxiety as measured in the EPM. In mice, 
exposures to an adult male for five minutes a day from postnatal day 28 through 32, increased 
anxiety on the EPM at day 33, but the effect was not observed when one hour of restraint was 
presented daily from postnatal day 28 through 32 and mice were tested in the EPM at day 33 
(Stone & Quartermain, 1997). However, neither five days of restraint nor isolation for 90 
minutes a day during adolescence had an effect on anxiety in the EPM when rats were tested 
during adolescence (Doremus et aI., 2009b). It may be that changes in anxiety sometimes do not 
surface until the rat matures. 
Other studies find that these increases in anxiety exist when the subjects are tested long 
after the cessation of the stressor. Chronic isolation, when it was coupled with the social stress of 
changing cage partners daily for 16 days, increased anxiety when rats were tested as adults at 
postnatal day 70, but not when tested during adolescence at postnatal day 45 (McCormick et aI., 
2008). Changing cage partners, a social stressor in adolescent mice, increased anxiety on the 
EPM when the mice were tested as adults (Schmidt et aI., 2007). Exposure to predator odor once 
during adolescence, at day 28, increased anxiety on the EPM as well as in an acoustic startle test 
of anxiety when rats were tested as adults, nine weeks old (Tsoory et aI., 2007). Alternating cage 
partners twice weekly for seven weeks also increased anxiety in adulthood, 12 months after the 
stressor (Sterlemann et aI., 2008). Chronic unpredictable stress during adolescence, from 
postnatal day 23 to 51, reduced anxiety on the EPM in adulthood, postnatal day 72, when the 
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stressors were severe, such as foot shock, but not with more mild stressors like a cage tilt (Pohl et 
_ aI., 2007). 
The effect of stress during adolescence on depressive behavior is less well studied than 
anxiety, and the few studies there are published present conflicting results. Housing animals in 
isolation during adolescence increased depressive behavior in the second session of the FST 
when tested during adolescence (Leussis et aI., 2008). Chronic unpredictable stress for four 
weeks during adolescence had no effect on behavior in the FST when measured in adolescence 
(Toth et aI., 2008). Chronic isolation paired with changing cage partners for 16 days during 
adolescence did not affect behavior in the FST when rats were tested as adults, postnatal day 70 
(Mathews et aI., 2008). It is possible that those studies showing no effect of stress on the FST 
may be a result of the rats habituating their corticosterone release to the stressor, considering 
direct administration of corticosterone increases depressive behavior in adults (Kalynchuk et aI., 
2004; Gregus et aI., 2005; Johnson et aI., 2006). 
Comparable to the research performed with adults, stress during adolescence alters 
structure of the brain areas linked to the affected behaviors previously discussed. Chronic 
unpredictable stress of both physical and social nature presented for 28 days during adolescence 
decreased hippocampal volume when measured three weeks following the stressor (Isgor et aI., 
2004). Swim, restraint and ether stress each presented once on different days during adolescence 
decreased levels of growth promoting proteins in the hippocampus (Uys et aI., 2006a). However, 
chronic unpredictable stress with mild stressors presented for four weeks during adolescence 
increased levels of growth promoting protein in the hippocampus and increased neurogenesis in 
the hippocampus when measured during adulthood (Toth et aI., 2008). Five days of isolation 
during adolescence decreased spinophilin, which is a protein found in dendritic spines, in the 
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basolateral amygdala and the central nucleus of the amygdala when measured during 
_ adolescence (Leussis et aI., 2008). The effect of stress on these structures is not as well studied in 
adolescence as in adults. Stress during adolescence has similar effects on behavior to stress 
experienced during adulthood, but those effects are enduring when the stressor is experienced 
during adolescence. Further study is still required to clarify the mechanisms of these enduring 
effects. 
The Present Study 
The above literature illustrates that in adults, exposure to stressors or to elevations in 
corticosterone can increase anxiety-like and depressive behavior, but these effects are not as clear 
when the stressor is administered during adolescence. This is partly because a wide variety of 
stressors have been used, and therefore it is difficult to compare results from study to study. 
Variations in individual responses to stressors and ability to habituate to stressors also make 
studies of chronic stressors difficult to interpret. Sterner and Kalynchuk (2010) argue that 
administering corticosterone in a uniform dose provides a more consistent effect with less 
variation due to individual differences. When presenting rats with a stressor individual rats will 
respond with different amounts of corticosterone, and each rat will habituate to the stressor at a 
different time. These issues do not exist in an experiment that gives a consistent dose of 
corticosterone to each·rat. Therefore experiments that involve the administration of 
corticosterone are more likely to yield conclusive results than those that use an arbitrarily chosen 
stressor. Several studies have shown corticosterone to increase depressive behavior in the FST 
(Kalynchuk et aI., 2004; Gregus et aI., 2005 Johnson et aI., 2006; Murray et aI., 2008; Marks et 
aI., 2009; Lee et aI., 2009; Gourley & Taylor, 2009). Additionally, corticosterone administration 
has been shown to produce the same effects on volume of brain regions that is observed in 
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patients with depression, decreased hippocampal and prefrontal cortex volume and increased 
- amygdala volume (reviewed in Sterner & Kalynchuk, 2010). However, the effects of' 
corticosterone administration during adolescence have not been studied. 
The purpose of the present study is to determine the effect of corticosterone 
administration during adolescence on the HPA axis and on anxiety-like and depressive behavior 
as measured by the EPM and FST respectively. Based on the other research in this area, 
corticosterone is expected to increase anxiety-like and depressive behaviors, just as 
corticosterone does in adults. However, it is predicted that exposure during adolescence will 
produce greater and longer lasting effects as compared to exposure during adulthood. It is 
expected that exposure to corticosterone during adolescence will cause increased release of 
corticosterone in response to a stressor, similar to that observed with social stressors (Mathews et 
aI., 2008), and that this altered HPA response will be enduring. It is also predicted that this HPA 
effect will be longer lasting in rats exposed to corticosterone during adolescence than in those 
exposed during adulthood. 
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Methods: Experiment 1 
Animals 
112 male Long-Evans rats, obtained from Charles River, St. Constant, Quebec, arrived in 
the colony, half were 22 days of age, adolescents, and half were 64 days of age, adults. They 
were housed in pairs in plastic (polycarbonate) cages and were provided with a plastic tube in 
each cage for enrichment throughout the experiment. Rats were identified by tail coloring with a 
felt tip marker. The rats were kept on a 12 hour light, 12 hour dark light cycle, and were given 
unlimited access to rat chow and water. Rats were given seven days to adjust to these housing 
conditions before the experimental procedures. All experimental procedures were consistent with 
National Institutes of Health Guide for Care and Use of Laboratory Animals (Publication No. 
85-23, revised 1985), and Canadian Council on Animal Care guidelines and were approved by 
the Brock University Institutional Animal Care and Use Committee. 
Treatment 
Starting on postnatal day 30 for the adolescents and 70 for the adults, each rat received 
one subcutaneous injection daily for 16 days, with the last injection given on postnatal day 45 or 
85. Half of the rats in each age group (n = 28 for each age) received vehicle (VEH) injections 
consisting of isotonic saline and 2% Tween-80 (purchased from Sigma-Aldrich, St. Louis, MO), 
and the other half (n = 28 for each age) received 40 mg / kg / mL corticosterone (CORT; 
purchased from Steraloids, Newport, RI; procedure as in Kalynchuk et aI., 2004; Sousa et aI., 
1998) suspended in the aforementioned solution. After injection the rat was immediately returned 
to the home cage, and each pair of rats that shared a cage were administered the same treatment. 
Previous research has found this dose of corticosterone injection to produce plasma 
corticosterone levels of approximately 2100 ng/mL one to four hours after the injection (Sousa et 
- ')~ -
aI., 1998). The rats were weighed once every three days, and the injection volume was 
- consequently adjusted. After the injection period rats were weighed once a week for the 
remainder of the experiment. 
Home cage behavior 
Home cage behavior was monitored to determine the effects of corticosterone treatment 
on social behavior. Monitoring began on the third day, and continued for a total of eight times for 
the adolescent group and five times for the adult group throughout the administration of 
injections. Ten minutes after injection, the rats were monitored while in their cages for 45 
minutes to determine if the injection type affected social interaction. A time sampling method 
was used, as described in McCormick et aI. (2007), whereby the behavior of each rat was 
recorded every three minutes for a total of 14 times per session. The behaviors were collapsed 
into the following categories associative (sniffing, following, allogrooming, mutual circling, 
pushing, play soliciting, playing, and lying down together) or non-associative (inactive, 
exploring, self-grooming, eating, and drinking). The adolescents were observed eight times, and 
the adults were observed five times. The total occurrences of each behavior in a session were 
tallied, and the percentage of behaviors observed that were associative was calculated for each 
day behavior was observed. 
Elevated Plus Maze 
The elevated plus maze (EPM) was made of four arms, two open and two closed, 
constructed out of grey painted plywood. The arms were 50 cm in length, and the walls enclosing 
the closed arm were 42 cm high. The sides of the open arm had a ledge that is 1.3 cm high. The 
maze was raised 78.74 cm off the ground, and was kept in a separate room from the colony. 
During testing the maze was illuminated with dim white light, and white noise (",60 dB) was 
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presented. Each rat was placed in the closed arm at the end farthest from the center and was 
-allowed to explore the maze for five minutes. All sessions were video taped, and tapes were later 
scored while blind to condition of the animal being tested. Tapes were scored for time spent in 
the open arm, closed arm and center as well as the total number of rears (when the rat stands on 
its hind legs) and head dips (when the rat reaches its head over the edge of the open arm). Half of 
each the vehicle and the corticosterone groups at each age were tested on the EPM one day after 
their last injection, on postnatal day 46 or 86 (n = 14 for both VEH and CORT groups at each 
age). The remaining rats were tested on the EPM 25 days after the last injection, at postnatal day 
70 or 110 (n = 14 for both VEH and CORT groups at each age). 
Forced Swim Test 
The forced swim test (FST) consisted of a clear cylinder 20.3 cm in diameter filled 24.1 
cm high with water such that a rat was unable to touch the bottom or climb over the side. The 
water was warmed to 26°C, and it was changed for every rat. Rats were placed in the water and 
left in the tank for twenty minutes. All sessions were videotaped, and tapes were later scored 
while blind to condition of the animal being tested. Tapes were scored for time spent immobile, 
swimming, diving and climbing. Of the 56 rats tested in the EPM immediately after the 
injections, 32 rats were tested with the FST the next day, postnatal day 47 or 87 (n = 8 for 
adolescent VEH, adolescent CORT, adult VEH, and adult CORT). Of the 56 rats that were tested 
in the EPM, 25 days after the last injection, 32 rats were tested with the FST the next day, 
postnatal day 71 or 111 (n = 8 for adolescent VEH, adolescent CORT, adult VEH, and adult 
CORT). 
FST Methodology 
Classically the FS T is administered in two sessions that are 24 hours apart, as described 
in the Introduction. An experimental manipulation, for example a dose of antidepressants, would 
be given between the two sessions, and the result would be observed on the second session 
(Porsolt et aI., 1977; Armario et aI., 1988; Detke et aI., 1995; Tejani-Butt et aI., 2003; Pechnick et 
aI., 2008). However, to determine if a chronic manipulation, for example 21 days of 
corticosterone injections, could produce a depression like state, the injections would be given 
and a only single session of the FST would be necessary to show increased depressive state 
(Kalynchuk et aI., 2004; Gregus et aI., 2005; Johnson et aI., 2006). Antidepressants can also 
decrease immobility in a one session FST (Overstreet & Griebel, 2004; Overstreet et aI., 2004). 
When compared directly, the effects of chronic corticosterone treatment for 21 days in adults 
were the same whether tested with a one day version of the test or a two day version (Marks et 
aI., 2009). Therefore, although several of the experiments discussed above employ the two 
session version of the FST, the experiments described here use a one session test. 
Plasma Corticosterone Determination 
To measure the stress-induced release of corticosterone in response to forced swim, blood 
was collected by tail nick from all of the rats directly after, 45 minutes after, and 90 minutes after 
the forced swim test (n = 8 for VEH day 47 and 87, CORT day 47 and 87, VEH day 71 and III 
and CORT day 71 and Ill). Blood samples were centrifuged at 3000 rpm and 4°C for 20 
minutes, and then the plasma was collected and stored at -80°C until the time of measurement. 
Plasma corticosterone concentrations were determined using a highly specific corticosterone 
antiserum (obtained from Dr. Greg Brown, University of Toronto) and PH] corticosterone (70.0 
Ci/mmol, Perkin Elmer, Wellesley, MA) as a tracer. The minimum detection level for the assay is 
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15 pg per tube. The antiserum cross-reactivity is less than 1 % with cortisol, testosterone, and 
- estradiol. Intra- and inter-assay reliability is less than 5% and 10% respectively. All samples for 
this experiment were measured at the same time. 
Statistical Analysis 
To facilitate interpretation given the number of variables and the predicted interactions, 
the administered in adolescence versus administered in adulthood groups were analyzed 
separately. Furthermore, the focus of the investigation was the effect of corticosterone treatment 
at each age, and age differences would be expected for most of the measures. Weight differences 
were analyzed using a repeated measures analysis of variance (ANOVA) with the between 
subject factor of treatment, and where appropriate these were followed up with t-tests. In cage 
behavior was analyzed with repeated measures ANOVA with treatment as a between subjects 
factor. Behavioral measures during the EPM were analyzed using multivariate analysis of 
variance (MANOVA) with between subject factors of treatment (corticosterone or vehicle) and 
timing of testing [soon after (Immediate groups) or weeks after (Enduring groups) treatment). 
When appropriate, these were followed up with MANOVAs for each of the different timing of 
testing groups with the between subject factor of treatment. The plasma concentrations of 
corticosterone were analyzed using a repeated measures ANOVA with treatment and timing of 
testing as the between subject factors. This was followed up with separate repeated measures 
ANOVAs for each timing of testing group. Fisher's protected least square differences were used 
for post hoc analyses where appropriate. An alpha level ofp < 0.05 was considered significant. 
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Table 1. 
Sample sizes of groups for each measure in Experiment 1. 
Adolescents Adults 
Immediate Enduring Immediate Enduring 
Treatment CORT VEH CORT VEH CORT VEH CORT VEH 
Weight 14 14 14 14 14 14 14 14 
Behaviorl 9 9 9 9 
EPM 132 132 14 14 14 14 122 14 
FST 8 92,3 8 62 8 8 66 8 
Cort after 4 3 4 4 2 1 3 2 
FST5 
1. Behavior was monitored in a chosen subset of cages during injection period; therefore rats 
were not differentiated between immediate and enduring. N is the number of cages monitored, 
each of which housed two rats. 
2. Data were lost after testing because of equipment failure or malfunction, thereby reducing the 
sample size by one. 
3. Two rats, that were treated with vehicle injections but not intended for use in the FST study, 
were accidentally tested in the FST, and therefore their data were included in the analysis. 
4. A pair of rats had body weights that were too low after corticosterone (cort) injections to 
undergo the FST because they were no longer buoyant. 
5. Corticosterone levels were only analyzed for those rats from which we were able to collect a 
usable sample at all three time points. 
6. Data were lost after testing because of equipment malfunction, thereby reducing the sample 
size by two. 
Results: Experiment 1 
In all data analyses, adolescents and adults are analyzed separately. Additional statistical 
analyses can be found in Appendix A. 
Weight 
A repeated measures ANOVA of weight for the adolescents with treatment as the between 
subjects factor revealed a significant two way interaction between time point and treatment, F 
(5,270) = 87.34, P < 0.001. Post hoc independent samples t-tests indicated that the treatment 
groups did not differ in weight, p = 0.92, on the first day of treatment, and on all other days, the 
corticosterone treated rats weighed less than the vehicle treated rats, p < 0.001 for all days, (see 
Figure 1). 
A repeated measures ANOVA of weight for the adults with treatment as the between 
subjects factor showed a significant two way interaction between time point and treatment, F 
(5,270) = 251.07, P < 0.001, such that vehicle treated rats were gaining weight, and 
corticosterone treated rats were losing weight over the duration of treatment. Post hoc 
independent samples t-test indicated that there was no difference between the treatment groups 
on day one, p = 0.50. On every other day weight was measured, corticosterone treated rats 
weighed less than vehicle treated rats, p < 0.001 for all days (see Figure 1). 
For the adolescents that were tested several weeks after treatment, a repeated measures 
ANOVA of weight each week after the administration of the injections indicated a significant 
interaction between time point and treatment, F(2,52) = 4.04, p = 0.02. Post hoc t-tests indicated 
that the corticosterone treated rats weighed significantly less than the vehicle treated rats, p < 
0.001 at each time points (see Figure 1). 
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F or the adults that were tested several weeks after treatment, a repeated measures 
- ANaVA of weight each week after the administration of the injections indicated a significant 
interaction between time point and treatment, F(2,52) = 22.03, p < 0.001. Post hoc t-tests 
indicated that the corticosterone treated rats weighed less than the vehicle treated rats, p < 0.001, 
at each time point (see Figure 1). 
Home Cage Behavior 
A repeated measures ANaVA of the percent of the behavioral observations among 
adolescents in which cage partners were associating with one another found a significant main 
effect of the day of observation, F(7,112) = 4.18, P < 0.001 (see Figure 2). There was no main 
effect of treatment, F(1,16) = 0.12, p = 0.74, and there was no interaction between treatment and 
day of observation, F(7,112) = 1.11, p = 0.36. 
A repeated measures ANaVA of percent of the behavioral observations among adults 
found that percentage of incidents in which cage partners were associating with one another 
differed from day to day of observation, F(4,64) = 5.50, P = 0.001 (see Figure 2). There was no 
main effect of treatment, F(1,16) = 0.003, p = 0.87, and there was no interaction between 
treatment and day of observation, F(4,64) = 1.04, p = 0.39. 
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Elevated Plus Maze 
All variables analyzed were checked to determine if there were correlations between the 
variables analyzed, and several variables are correlated with one another (see Table 2 and Table 
3). A MANOVA of time in the open arm, percent of entries to the open arm, time in the center, 
closed arm entries, head dips, rears, and latency to the open arm with treatment and time of 
testing as the between subjects factors, showed that, for rats treated in adolescence, there was a 
significant effect of time of testing on several variables in the EPM. Irrespective of type of 
treatment, rats treated in adolescence and tested several weeks after treatment demonstrated more 
time in the open arm, F(1,46) = 27.66, P < 0.001, a lower latency to reach the open arm, F(1,46) 
= 3.92, p = 0.05, a higher percent of entries to the open arm, F(1,46) = 26.61, P < 0.001, more 
head dips, F(1,46) = 12.58, p = 0.001, and more rears, F(1,46) = 26.15, p < 0.001, than did 
adolescents tested immediately after treatment, (see Figure 3). Rats treated in adolescence and 
tested several weeks later also spent more time in the center, F(1,46) = 9.76, p = 0.003, and they 
made more entries to the closed arm, F(1,46) = 4.86, P = 0.03, than did rats tested soon after 
treatment ended (see Figure 4). There were no significant effects of corticosterone treatment or 
interactions between time of testing and treatment, see Appendix A for details. 
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Figure 3. Means for anxiety related behaviors on the EPM in adolescent treated 
rats: A. time spent in the open arm, B. latency to reach the open arm, C. percent 
entries to the open arm, D. head dips, and E. rears. Error bars represent the 
standard error of the mean (SEM). * Indicates a main effect of time of testing, p = 
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Table 2. 
-Correlations of EPM Variables Grouped by Related Construct for Adolescent Corticosterone or 
Vehicle Treated Rats 
Anxiety Risk 
Time 
open 
Time open -
% open 
entries 
Latency to 
open 
Head dips 
Rears 
Time 
center 
% open Latency 
entries to open 
0.67* -0.67* 
-0.65* 
Head dips Rears 
0.84* 0.60* 
0.65* 0.42* 
-0.62* -0.42* 
0.47* 
Time 
center 
0.62* 
0.58* 
-0.77* 
0.51* 
0.47* 
* indicate statistically significant correlations, p = 0.05 or smaller. 
For rats treated as adults, a MANOVA of time in the open arm, percent of entries that are 
to the open arm, time in the center, closed arm entries, head dips, rears and latency to the open 
arm for rats treated as adults indicated that there was a significant interaction between treatment 
and time of testing on head dips, F(1,49) = 7.45, P = 0.009, and closed arm entries, F(1,49) = 
15.16, p < 0.001, and a near significant interaction between time of testing and treatment on time 
in the open arm, F(1,49) = 3.41, p = 0.07. Additional details are available in AppendixA. This 
analysis was followed up with a MANOVA for each time of testing group separately. 
F or those adults tested immediately after treatment, corticosterone treated rats entered the 
closed arms fewer times than did vehicle treated rats, F(1,26) = 7.01, p = 0.01. For those rats 
treated as adults and tested several weeks later, corticosterone treated rats entered the closed arm 
more often than did vehicle treated rats, F(1,25) = 8.73, p = 0.007 (see Figure 6). The rats treated 
with corticosterone as adults and tested several weeks later also performed more head dips than 
.:Sb 
did the corresponding vehicle treated rats, F(1,25) = 10.99, P = 0.003. There was a: near 
- significant trend for the rats treated with corticosterone as adults and tested several weeks later to 
spend more time in the open arm than those treated with vehicle, F(l,25) = 3.73, p = 0.07 (see 
Figure 5). 
Table 3 
Correlations of EPM Variables Grouped by Related Construct for Adult Corticosterone or 
Vehicle Treated Rats 
Anxiety Risk 
Time 
open 
Time open -
% open 
entries 
Latency to 
open 
Head dips 
Rears 
Time 
center 
% open Latency 
entries to open 
0.51 * -0.60* 
-0.74* 
Head dips Rears 
0.76* 0.25 
0.36* 0.28* 
-0.50* -0.35* 
0.31 * 
Time 
center 
0.15 
0.46* 
-0.56* 
0.04 
0.19 
* indicate statistically significant correlations, p = 0.05 or smaller. 
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Forced Swim Test 
Latency to Immobility: For rats treated with·corticosterone or vehicle in adolescence, an 
ANOVA of latency to immobility showed that those tested immediately after treatment had a 
greater latency to immobility than those tested several weeks later, F(I,27) = 16.04, p < 0.001. 
For rats treated in adulthood, anANOVA of latency to immobility found no significant effects of 
timing of testing or of treatment and no interaction between the two factors (see Figure 7). 
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Figure 7. The means for the amount of time in the FST before spending a 
minimum of five seconds immobile. Error bars represent the SEM. * 
Indicates where the time of testing group was significantly different, p < 
0.001. 
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Duration of Immobility: For rats treated in adolescence there was a time point by 
- treatment interaction F(3,81) = 2.73, P = 0.05. Additionally, rats treated in adolescence and tested 
several weeks later spent more time immobile than did rats tested immediately after treatment, F 
(1,27) = 52.0, P < 0.001. For both types of treatment there was a significant effect of time point, 
F(3,42) = 11.95, P < 0.001 for vehicle treated rats and F(3,45) = 43.67, P < 0.001 for 
corticosterone treated rats. This was followed with paired samples t-tests, which indicate that for 
as the rats spent more time immobile in the first five minutes of the test than any other time 
block for both rats treated with vehicle, p = 0.001, and corticosterone, p < 0.001. For the rats 
treated with corticosterone, rats spent more time immobile in the last five minute block of the 
test than during either the second, p = 0.007 or the third five minute block, p = 0.03. Overall 
corticosterone treated rats spent more time immobile as the test progressed, and the vehicle 
treated rats spent less time immobile in the first five minute block of the test than any other five 
minute block (see Figures 8 and 9). 
For the adults, there also was a significant time point by timing of testing interaction, F 
(3,78) = 3.00, p = 0.04. This was followed up with individual t-tests at each time point, which 
indicated that adults, tested several weeks after treatment, spent more time immobile during the 
first five minutes of the test than those tested immediately, p < 0.001, but were not different at 
any other time point (see Figure 10 and 11). 
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Duration of Swimming: For the rats treated in adolescence there was a time point by 
- treatment interaction, F(3,81) = 2.68, p = 0.05. For the rats treated in adolescence and tested 
immediately there was a significant interaction of time point by treatment, F(3,45) = 2.87, P = 
0.05. This was followed up by an independent sample t-test, which indicated that corticosterone 
treated rats were swimming more than vehicle treated rats only at the five minute time point, p = 
0.01 (see Figure 8). For those rats that were treated in adolescence and tested several weeks later 
there was no effect of time point or treatment (see Figure 9). See Appendix A for additional 
details. 
For the rats treated in adulthood, there was a time point by time of testing interaction, F 
(3,78) = 9.93, p < 0.001, and a near significant time of testing by treatment interaction, F(3,78) = 
2.52, p = 0.09. This was followed up with separate repeated measures ANOVAs of time spent 
swimming for each time of testing group. For the adult treated rats tested immediately after 
treatment there was a significant effect of time point, F(3,42) = 7.45, p < 0.001, such that rats 
swam less as the test progressed, and the same was true for those rats treated as adults and tested 
several weeks later, F(3,36) = 3.60, p = 0.02 (see Figures 10 and 11). For those rats treated as 
adults and tested several weeks later the interaction between time point and treatment 
approached significance F(3,36) = 2.15, p = 0.11. 
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Figure 10. The means for the time the adults rats tested for immediate effects spent engaging in 
the following behaviors in the FST, A. immobility, B. swimming, and C. climbing. Error bars 
represent the SEM. 
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Duration of Climbing: For the rats treated in adolescence there was a significant effect of 
time point, F(3,81) = 100.6, P < 0.001, such that rats climbed less as the test progressed. The rats 
treated in adolescence and tested several weeks later climbed significantly less than those tested 
immediately, F(1,27) = 6.02, P = 0.02. The interaction of treatment and time point approached 
significance, F(1,27) = 2.13, p = 0.16. 
For rats treated in adulthood the time point by treatment interaction was significant, F 
(3,78) = 3.35, P = 0.02, and the time point by time of testing interaction was also significant, F 
(3,78) = 6.87, p < 0.001. There was also a significant interaction of treatment by time of testing, 
F(1,26) = 5.11, p = 0.03, and a near significant three way interaction F(3,78) = 2.08, P = 0.11. 
F or those rats treated as adults and tested several weeks later there was a significant time point 
by treatment interaction, F(3,36) = 7.40, p = 0.001. This was followed up with an independent t-
test showing that the corticosterone treated rats climbed more than the vehicle treated rats at the 
five and ten minute time points, p < 0.001 and p = 0.02 respectively (see Figure 11). For those 
adults tested immediately there was a significant main effect of time point, F(3,42) = 22.25, p < 
0.001, such that rats climbed less as the test progressed (see Figure 10). 
Corticosterone after the Forced Swim Test 
Because of sampling difficulties, samples were not available for all time points. Thus, 
only rats with a complete data set across three time points were analyzed. A repeated measured 
ANOVA of the corticosterone concentration immediately, 30 minutes and 90 minutes after the 
FST, indicated that for the rats treated in adolescence there was a significant three way 
interaction of time point by treatment by time of testing, F(2,44) = 3.33, P = 0.05. For the 
adolescent treated rats tested immediately, there was a significant main effect of time point, F 
(2,20) = 7.11, P = 0.005, such that corticosterone levels decreased with time. Corticosterone 
levels were lower in corticosterone treated rats than in vehicle treated rats at all time points, F 
- (1,10) = 10.71, P = 0.008 (see Figure 12). For the rats treated in adolescence and tested several 
weeks later there was a significant main effect of time point, F(2,24) = 6.42, P = 0.006, such that 
corticosterone levels decreased with time. Although the interaction of treatment by time point 
missed statistical significance, F(2,24) = 2.45, P = 0.11, exploratory post hoc analyses were 
performed because the lack of statistical significance may have been because of low power. t-
tests at each time point found that corticosterone levels in the corticosterone treated group were 
higher than those of the vehicle treated group only at the zero time point, p = 0.04 (see Figure 
12). 
A repeated measures ANOVA of corticosterone concentration for rats treated as adults 
indicated that there was a main effect of time point such that corticosterone concentration 
decreased with time after the FST, F(2,8) = 8.12, p = 0.01. Additionally, there was a main effect 
of timing of testing such that rats treated in adulthood and tested several weeks later had lower 
corticosterone levels than those tested immediately, F(1,10) = 18.14, P = 0.02. 
4Y 
CORTICOSTERONE AFTER FST: 
ADOLESCENT TREATED 
A. 
40 -
35 -
:J' 30 
"'C 
C, 
2. 25-
(J) 
c: 
e (J) 20 -
iii 
0 15 -u 
:e 
8 10 
5 -
0-, 
B. 
40 -
35 -
:J' 30 -
~ 2. 25 -
(J) 
~ 20-
2 
t/) 
0 15 u 
:e 
8 10 
5 
T 
+" 1 
o min 
* 
IMMEDIATE 
I 
T' 
45 min 
lime after FST 
ENDURING 
Vehicle 
**[ C' ___ ortlcosterone 
90 min 
Vehicle 
___ Corticosterone 
O-~--------------~--------------~-----------------, 
Omin 45 min 
lime after FST 
90 min 
Figure 12. The means for the plasma concentrations of corticosterone measured after the FST 
for those adolescent rats tested A. soon after treatment and B. three weeks after treatment. 
Error bars represent the SEM. ** Indicates a main effect of treatment, p = 0.008. * Indicates a 
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Discussion for Experiment 1 
The main findings for Experiment 1 were that rats treated with corticosterone injections 
in adolescence displayed no difference in anxiety-like or depressive behavior as measured by the 
EPM and FST when compared to rats injected with vehicle during adolescence regardless of 
when they were tested. Rats treated with corticosterone injections during adulthood and tested 
several weeks later displayed a mildly increased anxiety behavior pattern in the EPM, and 
increased climbing in the FSTwhen compared to adult rats treated with vehicle. Rats treated 
with corticosterone injections in adolescence and tested immediately after treatment displayed a 
decreased HPA response to a stressor when compared to vehicle treated rats. Rats treated with 
corticosterone injections during adolescence and tested several weeks later showed an increased 
HPA response to a stressor when compared to vehicle treated rats. These results are discussed in 
greater detail below. 
Weight 
Rats treated with corticosterone had reduced weight gain compared to rats treated with 
vehicle that was evident as early as three days into the treatment. This is consistent with many 
previous reports that corticosterone administered in adulthood causes a decrease in body weight 
(Kalynchuk et aI., 2004, Gregus et aI., 2005, Johnson et aI., 2006). Previous studies have also 
shown that chronic stress in adolescence (e.g., McCormick et aI., 2007, Stone & Quartermain, 
1997) or adulthood (eg. Matuszewich et aI., 2007) causes reduced weight gain. Excess 
glucocorticoids, such as corticosterone, have been shown to induce insulin release, lipogenesis, 
gluconeogenesis, and protein catabolism, all of which individually could decrease body weight 
(reviewed in Dallman, 1984). Whereas stressed rats usually show recovery, such that within 
weeks they do not differ in weight within a few weeks after cessation of stress (McCormick et 
aI., 2004), the effects of corticosterone on weight were evident three weeks after treatment 
- irrespective of the age at which they are treated. Thus, the dose of corticosterone used here 
surpasses the effects of most chronic stress paradigms on physiological responses. 
In cage Behavior 
Corticosterone treatment did not seem to affect behavior in the home cage after injections 
whether treated in adolescence or in adulthood. In contrast, stressors in adolescence do alter 
behavior. Acute restraint stress for 30 minutes at postnatal days 28, 35, 42, and 49 decreased 
play behaviors and increased time rats spent resting in groups in the home cage, when measured 
up to one hour after the stressor (Klein et aI., 2010). This study also found that chronic restraint 
stress, 30 minutes every other day for 21 days decreased social investigation and increased time 
spent resting in groups when measured 24 hours after the last stressor (Klein et aI., 2010). Other 
work has found that rats that experienced a social stressor in adolescence, one hour of isolation 
with a new cage partner after return to the home cage, daily for 16 days were less social than rats 
that had experienced a non-social stressor, isolation alone (McCormick et aI., 2007). The 
discrepancy between these two studies may be explained by the different times at which behavior 
was monitored, the next day compared to immediate after stress, or the different durations of the 
stressor, 30 minutes compared to 60, or the administration period for the stressors, 21 days as 
opposed to 16. However, both studies do show chronic stressors experienced during adolescence 
have an effect on behavior in the home cage. It is possible that corticosterone did not have an 
effect on behavior in the home cage in the present experiment because the vehicle injections 
served as an acute stressor. Thus, both treatment groups may have been undergoing the effects of 
acute stress when they were monitored, thereby attenuating any treatment effect. 
Anxiety-like and Depressive Behavior 
Corticosterone treatment had no effect on any behavior in the EPM compared to vehicle 
treatment for the adolescent treated rats regardless of whether the rats were tested immediately or 
several weeks after treatment. There was no effect of corticosterone treatment during 
adolescence compared to vehicle treatment on either immobility or climbing behaviors in the 
FST. Adolescent rats treated with corticosterone and tested immediately spent more time 
swimming during the first five minutes of the FST than those treated with vehicle. However, 
because this effect was not accompanied by the expected increase in immobility after treatment 
with corticosterone, it should not be interpreted as decreased depressive behavior. Immobility is 
the behavior that represents the depressive state (Porsolt et aI., 1977), and therefore without a 
difference in immobility, differences in other behaviors are not truly representative of an effect 
on depressive behavior. There was also a non-significant trend for the corticosterone treated rats 
to spend less time climbing during the first five minutes than those treated with vehicle. This 
may represent the corticosterone treated rats making less of a concerted effort to escape the test. 
Swimming around the border when the vehicle treated rats would have been climbing 
demonstrates a decreased effort to escape, which would be consistent with the literature that 
shows corticosterone treatment administered during adulthood increases depressive behavior in 
the FST as compared to rats treated with vehicle (Kalynchuk et aI., 2004; Gregus et aI., 2005; 
Johnson et aI., 2006). Despite the marked effect of corticosterone treatment on weight, 
corticosterone did not produce the expected increase in depressive behavior in the FST or 
anxiety-like behavior in the EPM when administered either during adolescence or adulthood. 
The majority of the literature shows that exposure to chronic stress of various durations 
during adulthood with a variety of stressors increases anxiety in the EPM (Vyas et aI., 2002; 
2004; Gamiero et aI., 2006; Adamec et aI., 2006; Pego et aI., 2008; Bondi et aI., 2008; Bowman 
et aI., 2009; Noschang et aI., 2009). Additionally direct chronic administration of corticosterone, 
- 25 mg/kg for 28 days, during adulthood has been shown to increase anxiety on the EPM (Pego et 
aI., 2008). Both removing the adrenal glands and administering drugs that prevent the production 
of corticosterone abolish the increased anxiety observed in rats exposed to chronic stress (Calvo 
et aI., 2001). Treating rats with a GR antagonist also prevents the increased anxiety induced by 
chronic stress (Korte et aI., 1995). Taken together these studies show that stress increases anxiety 
because of the exposure to corticosterone. 
The reason corticosterone was not observed to increase anxiety or depressive behavior 
compared to vehicle treated rats when administered during adolescence may be that the vehicle 
inj ections were stressful enough to also produce an increase in anxiety. This would mean that the 
injections were stressful enough that the corticosterone had no effect beyond what the injections 
themselves had already caused. One problem for this last possibility, though, is that I found no 
difference between the treatment groups when administered in adulthood, whereas there are 
several reports of differences between corticosterone-injected and vehicle-treated rats in 
depressive behavior in the FST (Kalynchuk et aI., 2004; Gregus et aI., 2005; Johnson et aI., 2006; 
Lee et aI., 2009). However, a cross comparison of studies demonstrates that duration of the 
administration of corticosterone is an important factor in demonstrating increased depressive 
behavior. Those studies with durations of corticosterone administration that are longer than that 
used here, 16 days, do show corticosterone treatment increased depressive behavior in the FST, 
but studies using a duration of administration shorter than that used here do not show (reviewed 
in Sterner & Kalynchuk, 2010). Thus, it may be that 16 days of corticosterone treatment is 
insufficient number of days for corticosterone treatments to be effective at either age. Thus, no 
support was found for that adolescents would show greater lasting effects of corticosterone 
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treatment on anxiety-like and depressive behavior compared to adults. It is also possible that the 
-reason for the lack of treatment effects is for different reasons at each age: effect of stress of 
injection masking the effect of corticosterone compared to vehicle in adolescents, whereas in 
adults, the length of treatment was insufficient. A second experiment was designed to remove 
the possibility of injection stress (described later). 
The design of the experiment allowed me to also investigate age differences in behavior 
on the FST and on the EPM by comparing the behavior of rats tested as adolescents to those 
tested as adults within the adolescent treatment groups. Adolescent rats spent less time on the 
open arm, had a higher latency to reach the open arm, a lower percentage of entries into the open 
arm, performed fewer head dips, and fewer rears than did adult rats (postnatal day 70), all 
indications of greater anxiety-like behavior in adolescence than in adulthood (Wall & Messier, 
2001; Doremus et aI., 2006). Additionally, adolescent rats were less active (entries into closed 
arms) and spent less time assessing risk (time in center) than those tested several weeks after 
treatment. Adolescent rats also displayed decreased levels of depressive behavior on the FST in 
that they had a higher latency to immobility, spent less time immobile and spent more time 
swimming and climbing than did adults. Other studies have shown adolescents, postnatal day 45 
and 48, as acting less anxious than adults, postnatal day 60 and 61, in the EPM (Imhof et aI., 
1993, Macri et aI., 2002). Another study has shown young adolescent mice, postnatal day 21 to 
have decreased depressive behavior in the FST as compared to. mice in mid-adolescence, 
postnatal day 42, and adults, postnatal day 56, which were not different from one another 
(Hefner & Holmes, 2007). Therefore the results reported here are not consistent with other 
literature, but it is possible that the age difference observed here represents recovery from a 
stressor, injections. Adolescents have been shown to be more susceptible to the effects of 
stressors than adults (reviewed in McCormick et aI., 2010), and therefore it is possible that the 
- adolescents of either treatment group were receiving a chronic stressor. The behavior of the 
adolescents tested several weeks after treatment was similar to that of the adults tested 
immediately, therefore those groups are most likely reflecting typical adult behavior. It is 
impossible to determine from this experiment whether the age difference observed here reflects 
an age difference or recovery from the stress of injection. Therefore a second experiment was 
designed with the purpose of observing the effects of corticosterone without the confounding 
stress of injection, which will be discussed in the second portion of this report. 
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The adult rats treated with corticosterone produced unusual behavior patterns on the EPM 
and the FST as compared to adults treated with vehicle. However, these rats were severely 
underweight, and consequently they were suffering from health issues. It is entirely unclear 
whether their behavior could be attributed to the corticosterone treatment or the health issues 
they experienced as a consequence of the corticosterone treatment. Therefore a second 
experiment employed a less severe method of administering corticosterone, which will be 
discussed in the second portion of this report. 
The variables measured on the EPM were correlated with one another in a manner that 
was expected based on factor analyses of behavioral measures the EPM (reviewed in Wall & 
Messier, 2001), which provides some indication that the analysis of behavior in the EPM was 
performed appropriately. 
HPA Response to a Stressor for Adolescent Treated Rats 
Despite the lack of differences in behavior between corticosterone and vehicle treated 
rats, the groups differed in corticosterone release after the FS T. When tested soon after treatment 
in adolescence, corticosterone concentrations were lower in corticosterone-treated rats than in 
vehicle injected controls. This is consistent with the finding that chronic corticosterone treatment 
- in adults reduced corticosterone response to forced swim (Johnson et aI., 2006); The effect 
observed here is likely the result of severe inhibition of the adrenal gland. Chronic administration 
of high levels of corticosterone would increase activation of the negative feedback system within 
the HPA, which would shut down corticosterone production in the adrenal gland. The immediate 
testing most likely did not allow sufficient time for the adrenal gland to recover from such high 
levels of inhibition, and therefore the adrenal gland would have depleted its stores of 
corticosterone. Therefore the dampened corticosterone response to a stressor observed in 
adolescent treated rats tested soon after treatment is likely the result of chronic corticosterone 
treatment shutting down corticosterone production in the adrenal gland. 
When tested several weeks after treatment, corticosterone-treated rats displayed an 
increased release of corticosterone in response to the FST compared to vehicle injected controls. 
Thus, exposure to high levels of corticosterone in adolescence produced an enduring change in 
the HPA axis, such that the release of corticosterone in response to a stressful event was 
increased. The reports of enduring effects of chronic stressors on later HPA function are mixed. 
Consistent with my results, Isgor et aI. (2004) found a prolonged corticosterone response to a 
novel stressor in adulthood after repeated unpredictable physical stress during adolescence. 
Several studies have found unaltered HPA response in adult males after experiencing a stressor 
during adolescence (Maslova, et aI., 2002, Mathews et aI., 2008, McCormick et aI., 2005, 
Overmier & Murison, 1991, Toledo-Rodriguez & Sandi, 2007, Wright et aI., 2008). Other studies 
have found changes in basal levels of corticosterone in adult males that had experienced chronic 
stress during adolescence (Toth et aI., 2008, Sterlemann et aI., 2008, Schmidt et aI., 2007, Uys et 
aI., 2006a, Uys et aI., 2006b, Shaffery et aI., 2006, Lepsch et aI., 2005). Our findings indicate that 
high levels of corticosterone present during adolescence alter the development of the HPA axis 
_ such that it becomes more reactive to stressors experienced in adulthood. This effect may require 
repeated exposures to consistently high levels of corticosterone. Thus, even though injection 
alone is stressful, it does not mimic the effect of corticosterone injection on stress responses. 
Further these results show that the lack of behavioral results may be substantive rather than 
representative of an insufficient dose because effects were observed on the HPA. 
One possible mechanism for the heightened HPA response in rats treated with 
corticosterone during adolescence and tested several weeks after treatment is neuronal 
remodeling in the hippocampus. Several studies have shown that chronic stress (Galea et aI., 
1997; Vyas et aI., 2002) and corticosterone administration (Woolley et aI., 1990; Watanabe et aI., 
1992; Magarinos et aI., 1998; Cerqueira et aI., 2005; 2007) can cause dendritic atrophy in the 
hippocampus of adults. The hippocampus is an important site of negative feedback for the HPA 
axis, and therefore damage to the hippocampus may decrease the negative feedback produced in 
response to high levels of circulation corticosterone (reviewed in de Kloet et aI., 1998). This is a 
suggested mechanism for the hypercortisolism observed in patients with depression (reviewed in 
de Kloet et aI., 1998). In adults dendritic atrophy in the hippocampus resulting from stress is 
reversible (Vyas et aI., 2004). However, the hippocampus is a site of ongoing development 
during the adolescent (reviewed in Lupien et aI., 2009), and therefore dendritic atrophy in the 
hippocampus that occurs during adolescence may be longer lasting than that observed during 
adulthood. It is possible that remodeling in the hippocampus as a result of corticosterone 
exposure during adolescence is the mechanism behind the increased HPA response observed in 
the rats treated with corticosterone during adolescence and tested several weeks after treatment 
as compared to those treated with vehicle injections. 
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The same argument could be made for the prefrontal cortex as the locus oflhe 
- mechanism for increased HPA response observed in corticosterone treated adolescents tested 
several weeks after treatment as compared to the corresponding vehicle treated control group. 
The prefrontal cortex undergoes dendritic reorganization after exposure to chronic stress during 
adulthood (Wellman, 2001; Seib & Wellman, 2003). The prefrontal cortex is also a site of 
negative feedback for the HPA axis (reviewed in de Kloet et aI., 1998), and the prefrontal cortex 
undergoes development during adolescence (reviewed in Lupien et aI., 2009). Therefore it is just 
as possible that corticosterone exposure during adolescence induces enduring alterations in 
dendritic morphology of the prefrontal cortex, which is in tum responsible for the decreased HPA 
control resulting in the increased HPA response observed in those adolescents treated with 
corticosterone and tested several weeks after treatment as compared to the corresponding vehicle 
treated control group. The lasting effects of corticosterone may be entirely peripheral to the 
nervous system, since there was no marked effect of corticosterone treatment on behavior but 
extreme effects on weight and corticosterone release. It is possible that the differences in 
corticosterone release observed are based entirely at the level of the adrenal gland. 
HPA Response to a Stressor for Adult Treated Rats 
There was some support for the hypothesis that the effects of corticosterone treatment on 
corticosterone release would be greater when administered in adolescence than when 
administered in adulthood. There was no effect of corticosterone treatment during adulthood on 
corticosterone response to a stressor regardless of whether the rats were tested for immediate or 
enduring effects. For those adult treated rats tested immediately, the inability to replicate 
decreased corticosterone response observed in the adolescent treated rats in the present study and 
in other studies of adult rats (Johnson et aI., 2006) is likely a result of the small sample size. The 
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dramatic weight loss over the course of the experiment in adult rats made the collection of blood 
- samples more difficult than anticipated. Among those adults tested several weeks after treatment 
there is scant difference in corticosterone response to the FST. Although it is possible that an 
effect of corticosterone treatment would become apparent with a larger sample size, it is more 
likely that there is no enduring effect of corticosterone treatment on the adult HPA. 
Conclusions 
The results from this experiment indicate that corticosterone administration during 
adolescence can have enduring effects on the HPA axis and on weight. However, effects of 
corticosterone administration on anxiety-like and depressive behavior were not observed. One 
possible explanation for the lack of behavioral effects is that the corticosterone treated group was 
being compared to a group of rats that had undergone a chronic mild stressor, the vehicle 
injections. Further investigation is required to determine if corticosterone administration can 
affect anxiety-like and depressive behavior when compared to unstressed controls, and if 
adolescents are more sensitive to corticosterone treatment than are adults. 
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Introduction: Experiment 2 
As discussed above, one possible explanation for the lack of clear effects of 
corticosterone on the EPM and FST may be that the vehicle injections represent a stressor, which 
would have similar effects to corticosterone administration. Therefore both groups may be 
experiencing the same effects on behavior. The purpose of the second experiment was to 
circumvent this issue by administering corticosterone in the drinking water. This way rats would 
receive corticosterone without any additional stressors, and the control group would be without a 
potentially confounding stressor. 
Administering corticosterone in the drinking water at a concentration of 400 Jlg/mL 
dissolved with 2.4% ethanol for 21 days has been shown to elevate plasma levels of 
corticosterone in adult rats such that concentrations consistently remain at levels similar to that 
experienced at the diurnal peak (Magarinos et aI., 1998). This study also demonstrated that 
corticosterone administration in drinking water reduced weight compared to ethanol treated 
controls (Magarinos et aI., 1998). However, when measured two weeks after treatment, 
corticosterone administered in the drinking water, 50 Jlg/mL, had no effect on basal levels of 
corticosterone in adult rats (Gourley &Taylor, 2009). Corticosterone administration in drinking 
water at a concentration of35 Jlg/mL for 28 days, has also been shown to dampen the 
corticosterone response to a novel stressor when tested soon after treatment (David et aI., 2009). 
These studies demonstrate that extended exposure to corticosterone in drinking water can affect 
the HPA axis in adults, but the effects are not enduring. 
Corticosterone administration in the drinking water has also been demonstrated to alter 
anxiety-like and depressive behavior in rodents. Administering 50 J.!g/mL of corticosterone to 
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rats or 25 Jlg/mL to mice dissolved in the drinking water for 14 days with a 6 day weaning 
- period, whereby the dose was decreased incrementally decreased, increased depressive behavior 
in the FST and decreased sucrose consumption, a measure of anhedonia in the rodent (Gourley et 
aI., 2008; Gourley & Taylor, 2009). However, mice given 35 J1,g/mL corticosterone in their 
drinking water for four weeks demonstrated no effect on their behavior in the FST compared to 
vehicle treated controls, but corticosterone treatment did increase time spent in the center of the 
open field test, which is indicative of higher levels of anxiety (David et aI., 2009). However, 
when rats were tested two weeks after treatment, corticosterone treatment for 14 days with six 
days of the aforementioned weaning procedure, did not affect anxiety-like behavior on the EPM 
(Gourley & Taylor, 2009). These studies do not provide a clear view of the effects of 
corticosterone on behavior, possibly because of the different doses and durations of 
administrated drug. It is also possible that the weaning period used initially by Gourley et aI. 
(2008) alters the effects of corticosterone on behavior in a different manner than corticosterone 
that is given at a consistent dose. Further study would be required to determine how 
corticosterone administered in drinking water can affect these behaviors. 
The present study will demonstrate whether corticosterone administered in the drinking 
water during either adulthood or adolescence can produce an effect on depressive behavior and 
HPA response to a stressor and if those effects will be enduring. It is predicted that depressive 
behavior will increase in rats treated with corticosterone, and that increased depressive behavior 
would be longer lasting in adolescent treated rats. It is predicted that for rats of either age tested 
soon after treatment, corticosterone will dampen the HPA response to a stressor, as it did in 
Experiment 1. It is also predicted that for rats tested several weeks after treatment and treated 
during adolescence, the HPA response to a stressor will be increased, as it was in Experiment 1, 
but there will be no enduring effect of corticosterone treatment in adult rats tested several weeks 
-after treatment. 
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Methods: Experiment 2 
Animals 
74 male Long-Evans rats, obtained from Charles River, St. Constant, Quebec, arrived in 
the colony, 36 of them at postnatal day 22, 16 at postnatal day 60 and 20 at day postnatal 67. 
They were housed in pairs in polycarbonate cages and were provided with one plastic tube in 
each cage for enrichment. Rats were identified by tail coloring with a felt tip marker. The rats 
were kept on a 12 hour light, 12 hour dark, light cycle, and were given unlimited access to rat 
chow and water at all times. Rats were given at least four days to adjust to these housing 
conditions before the beginning of the experimental procedures. All experimental procedures 
were consistent with National Institutes of Health Guide for Care and Use of Laboratory Animals 
(Publication No. 85-23, revised 1985), and Canadian Council on Animal Care guidelines and 
were approved by the Brock University Institutional Animal Care and Use Committee. 
Drinking Water Treatment 
At postnatal day 30 or 70 the drinking water was replaced with either a solution of 400 
flg / mL corticosterone (purchased from Steraloids, Newport, RI) and 2.5 % ethanol (n = 32, half 
started on day 30 and half on day 70), which is necessary to get the corticosterone to dissolve. 
To ensure that any effects observed were the result of corticosterone treatment and not ethanol 
exposure, a second group was given 2.5% ethanol (n = 20, half started on day 30 and half on day 
70), and the third group was given plain water (n = 20, half started on day 30 and half on day 
70). Each solution was colored with a different food coloring so that they would be easily 
distinguished from one another. After 16 days, on postnatal day 46 or 86, regular drinking water 
(tap water) was provided and treatment was removed. During treatment, the mass of water 
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consumed was measured every two days. Rats were weighed before and after the 16 days of 
- treatment, but were not handled during the c6urse of treatment, except for cage cleaning, which 
occurs three times a week. Using weight at the starting and ending of treatment, the dose of 
ethanol and of corticosterone consumed by the pair of rats in a cage over a two day period was 
calculated. To calculate the doses of ethanol and corticosterone, the density of each solution was 
determined by weighing one mL of each solution, because consumption was measured in mass. 
Using the beginning and ending weights, the approximate weight at the eighth day of treatment 
was extrapolated, and the ethanol and corticosterone doses for the seventh and eighth day were 
calculated based on this weight. 
Forced Swim Test 
All rats in this experiment were tested on the FST, either soon after treatment (postnatal 
day 47 or 87, depending on age at treatment) or long after treatment (postnatal day 71 or 111, 
depending on age at treatment) using the same procedure for the FS T as described in experiment 
one. 
Plasma Corticosterone Determination 
To determine the amount of corticosterone released after the FST, blood was collected by 
tail nick from each of the rats immediately, 45 minutes and 90 minutes after removal from the 
test. On the next day, a blood sample was obtained to provide a baseline level of corticosterone. 
No baseline was obtained before the FST in order that behavior in the FST would not be affected 
by the blood sampling. All blood samples were centrifuged at 3000 rpm and 4 °C for twenty 
minutes, and then the plasma was collected. Plasma samples were stored at -20°C until they 
were measured. Corticosterone concentrations were determined using an enzyme-linked 
immunosorbentassay kit (purchased from Neogen, Lansing MI). Corticosterone was extracted 
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from the samples by dissolving it in ethyl ether and then removing the organic layer containing 
the ether and all steroids from the original sample. The ether was evaporated off and the steroids 
were reconstituted in a buffer provided in the kit. The assay was run entirely as specified in the 
instructions for the kit; except that the reconstituted samples were diluted two fold what is 
instructed in the kit, in order for stress levels of corticosterone to be readable within the standard 
curve. The minimum detection level for the assay is 1 Jlg per tube. The antiserum cross-reacts 
with deoxycorticosterone (38%), and only slightly with cortisol (1.1 %), testosterone (0.12%), 
and estradiol « 0.01 %). The intra- and inter-assay reliability are both less than 10%. The 
samples for experiment 2 were run at two different times, once included all rats tested in the FST 
two days after removal of treated water, and another run consisted of all the rats tested 25 days 
after the removal of treated water. 
Statistical Analysis 
As in Experiment 1, analyses were performed separately on adolescent-treated and adults-
treated. Weight differences were analyzed using repeated measures ANOVAs with the between 
subject factor of treatment. Behavior during the FST was analyzed using a repeated measures 
ANOVA for each variable considered with treatment and timing of testing as the between 
subjects factors, the results of which can be found in Appendix A. This was followed up with a 
repeated measures ANOVA for each variable considered at each timing of testing group with 
treatment as the between subject factor. The plasma levels of corticosterone were analyzed using 
a repeated measures ANOVA with timing of testing and treatment as the between subjects 
factors. This was followed up where appropriate with a repeated measures ANOVA for each 
timing of testing group with treatment as the between subject factor. Basal levels of 
corticosterone were analyzed with a separate ANOVA for each timing of testing group using 
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treatment as the between subject factor. Fisher's protected least square differences 'were used for 
- post hoc analyses where appropriate. An alpha level ofp < 0.05 was considered significant. 
Table 4. 
Sample sizes of groups for each measure in Experiment 2. 
Immediate Enduring 
CORT ETHANOL WATER CORT ETHANOL WATER 
Adolescents 
Weight 8 6 6 8 4 4 
Intake! 4 3 3 4 2 2 
FST 8 6 6 8 4 4 
Cort 2 8 6 5 8 4 4 
Adults 
Weight 8 6 6 8 4 4 
Intake! 4 3 3 4 2 2 
FST 8 6 6 8 4 4 
Cort 2 6 5 3 8 4 4 
1. N indicates number of bottles, each of which is shared between two rats. 
2. Corticosterone measured after the FST data were only analyzed for those rats from which we 
were able to collect a usable sample at all three time points. 
Results: Experiment 2 
In all data analyses adolescents and adults are analyzed separately, except for the doses of 
ethanol and corticosterone. In these cases it is important to note whether the ages were receiving 
different doses of either ethanol or corticosterone. Additional statistical analyses can be found in 
AppendixA. 
Weight 
For rats treated in adolescence, a repeated measures ANOVA of weight measured on the 
first and last days of treatment for the rats found an interaction of treatment and time point, F 
(2,33) = 12.91, P < 0.001. This was followed up with a separate ANOVA of weight for each day 
weight was measured. There was no significant difference between treatment groups on the first 
day of treatment. On the last day of treatment there was a significant effect of treatment, F(2,33) 
= 7.41, P = 0.002, and the post hoc analyses showed that corticosterone treated rats weighed less 
than ethanol treated rats, p = 0.035, and corticosterone treated rats weighed less than rats given 
plain water, p = 0.001, but water and ethanol groups were not significantly different from one 
another (see Figure 14). 
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Figure 14. The means for the body weights of A. adolescents and B. adults during 
treatment (unshaded) and for those rats tested three weeks later (shaded). Error bars 
represent the SEM. * Indicated significantly different from the water group, p = 
0.01, and ** indicates significantly different from both corresponding ethanol and 
water treatment groups, p = 0.05 or less. 
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For the adult treated rats, a repeated measures ANOVA of weight measured on the first 
- and last days of treatment found a significant interaction between treatment and time point, F 
(2,33) = 18.92, p < 0.001. This was followed up with a separate ANOVA of weight for each day 
it was measured. On the first day of treatment there was no significant difference between 
treatment groups F(2,33) = 2.60, p = 0.08, although rats given ethanol tended to be heavier. On 
the last day of treatment there was a significant effect of treatment, F(2,33) = 20.89, p < 0.001. 
Corticosterone treated rats weighed less than ethanol treated rats, p < 0.001, and less than rats 
with plain water, p < 0.001. Ethanol and water groups were not significantly different from one 
another (see Figure 14). 
A repeated measures ANOVA of weight measured after treatment for the rats treated in 
adolescence and tested several weeks later indicated that there was a significant interaction 
between week the weight was measured and treatment, F(2,13) = 5.73, p = 0.02. This was 
followed up with individual ANOVAs of weight for each week. At the first week after treatment 
there was a significant effect of treatment, F(2,13) = 26.05, p < 0.001. The post hoc analyses 
indicated that corticosterone treated rats weighed less than ethanol treated rats, p = 0.03, that 
corticosterone treated rats weighed less than rats with plain water, p < 0.001, and that ethanol 
treated rats weighed less than those with plain water, p = 0.01. By the second week after 
treatment there was no effect of treatment on weight (see Figure 14). 
For rats treated as adults, the main effect of treatment of weight in the weeks after 
treatment was significant, F(2,13) = 5.42, p = 0.02. Corticosterone treated rats weighed less than 
ethanol treated rats, p = 0.01, corticosterone treated rats weighed less than those with plain water, 
p = 0.03, but ethanol and water groups did not differ. 
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Treated Water Intake 
For the adolescent treated rats, a repeated measures ANOVA of two days worth of treated 
water intake on the second, eighth, and sixteenth days of treatment indicated a significant main 
effect of time point F(2,30) = 15.24, P < 0.001, with intake increasing over the course of 
treatment. There was an effect of treatment, F(2,15) = 4.08, P = 0.04. Corticosterone treated rats 
drank less than the plain water group, p = 0.02, ethanol treated rats drank less than the water 
group, p=0.05, but the corticosterone and ethanol groups did not differ. 
For adult-treated rats, there was a main effect of time point such that rats drank more over 
time in all groups, F(2,30) = 6.43, p = 0.005, but there was no effect of treatment, F(2,15) = 1.80, 
P = 0.20 (see Figure 15). 
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Figure 15. The means for the amount of treated water drank per cage, i.e. by two rats, in 
two days for A. adolescent treated rats and B. adult treated rats. Error bars represent the 
SEM. * Indicates groups significantly different from water, p = 0.05 or less. 
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Ethanol Dose 
A repeated measuresANOVA of ethanol dose on the second, eighth, and sixteenth days of 
treatment showed that there was a significant interaction between day of treatment and age 
group, F(2,36) = 9.12, p = 0.001. Follow up repeated measures ANOVAs of ethanol dose for 
each age group showed that for the adolescent treated rats ethanol dose decreased with time, F 
(2,24) = 16.69, p < 0.001, but not for the adult treated rats, F(2,24) = 1.04, p = 0.37 (see Figure 
16). Follow up independent samples t-test indicate that the adolescent treated rats ingested a 
larger dose of ethanol on the first two days of treatment, p < 0.001, and a near significant trend 
for the seventh and eighth days of treatment, p = 0.06, but not by the last two days of treatment, p 
=0.20. 
Corticosterone Dose 
A repeated measures ANOVA on corticosterone dose found an interaction between day of 
treatment and age, F(2,28) = 6.05, p = 0.007. For the first two days of intake the adolescents 
consumed a higher dose of corticosterone than the adults p < 0.001, but not for the seventh and 
eighth days, p = 0.13 or for the last two days of intake, p = 0.41 (see Figure 16). 
DOSAGE 
A. 
12 
~ 
::J 10 
.s 
~ 8 
o 
~ 6 
.e 
(I) 
~ 4 
-~ 2 
o 
o +_---1..------''---_ 
Day 2 
B. 
_ 200 
C) 
~ 180 
'[160 
Q) 140 
~ 120 c 
100 Q) 
c 80 e 
Q) 60 Ui 
0 40 0 
1:: 20 0 (.) 0 
* 
* 
Day 2 
ETHANOL 
Day 8 
Day of Treatment 
CORTICOSTERONE 
Day 8 
Day of Treatment 
D Adolescent Ethanol 
D Adolescent Corticosterone 
1m Adult Ethanol 
111 Adult Corticosterone 
Day 16 
D Adolescent 
1m Adult 
Day 16 
Figure 16. The means for the average dose ingested by one cage, i.e. by two rats, in two 
days measured at three time points across treatment for rats treated with A. Ethanol, * 
indicates a significant difference between age groups at that time point, p = 0.01 or less. 
or B. Corticosterone, * indicates that the adults ingested a significantly lower dose, p < 
0.001. Error bars indicate the SEM. 
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Farced Swim Test 
Latency to Immobility: An ANOVA of latency to remain immobile for a minimum of five 
seconds in the adolescent treated rats indicated that there was a main effect of time of testing 
such that adolescent treated rats tested immediately took more time than those tested several 
weeks later to become immobile, F(1,30) = 22.90, P < 0.001, but the same was not true for the 
adult treated rats, F(l,30) = 0.97, p = 0.33 (see Figure 17). 
Duration of Immobility: For adolescent treated rats there was a significant effect of time 
point, F(3,90) = 76.31, P < 0.001, such that as the test progressed rats spent more time immobile. 
There was a significant effect of time of testing, F(1,30) = 28.35, P < 0.001, such that rats treated 
in adolescence and tested several weeks later spent more time immobile than those tested 
immediately. There was no effect of treatment, F(2,30) = 0.12, p = 0.89, and no interaction 
between time of testing and treatment, F(2,30) = 0.17, p = 0.84 (see Figures 18 and 19). 
For adult treated rats there was a significant effect of time point, F(3,90) = 88.61, p < 
0.001, such that as the test progressed rats spent more time immobile. There was no effect of 
time of testing, F(l,30) = 0.71, p = 0.41, no effect of treatment, F(2,30) = 1.00, P = 0.38, and no 
interaction between time of testing and treatment, F(2,30) = 0.48, p = 0.62 (see Figures 20 and 
21). 
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Duration of Swimming: For the adolescent treated rats those rats that were tested several 
- weeks after treatment swam less than those rats that were tested immediately after treatment, F 
(1,30) = 22.64, p < 0.001, and there was a main effect of time point such that adolescent treated 
rats swam less as the test progressed, F(3,90) = 3.72, p = 0.014. There was no effect of treatment, 
F(2,30) = 0.01, P = 0.99, and there was no interaction between time of testing and treatment, F 
(2,30) = 0.07, P = 0.94 (see Figures 18 and 19). 
For the adults there was no effect of time point, F(3,90) = 1.33, p = 0.27, no effect of time 
of testing, F(l,30) = 2.39, P = 0.13, no effect of treatment, F(2,30) = 1.95, P = 0.16, and no 
interaction between time of testing and treatment, F(2,30) = 1.45, P = 0.25 (see Figures 20 and 
21). 
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Figure 18. The means for behaviors performed by adolescents tested 
immediately during the FST, A. immobility, B. swimming, and C. climbing. 
Error bars represent the SEM. 
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c. climbing. Error bars represent the SEM. 
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Duration of Climbing: Because there was an interaction between time point and time of 
-testing at both time of treatment ages (results reported in Appendix A), the time of testing groups 
were analyzed separately for each age group. 
For rats treated in adolescence and tested immediately, rats climbed less as the test progressed, F 
(3,51) = 150.47, P < 0.001, but there was no effect of treatment on time spent climbing, F(2,17) = 
2.10, P = 0.15 (see Figure 22). For rats treated in adolescence and tested several weeks, rats later 
climbed less as the test progressed, F(3,39) = 64.99, p < 0.001, but there was no effect of 
treatment on climbing, F(2,13) = 0.61, p = 0.56 (see Figure 19). 
For adult treated rats tested immediately, rats climbed less as the test progressed, F(3,51) 
= 145.70, P < 0.001, but there was no effect of treatment, F(2,17) = 1.36, p = 0.28 (see Figure 
24). For rats treated as adults and tested several weeks later, rats climbed less as the test 
progressed, F(3,39) = 57.88, P < 0.001, but there was no effect of treatment, F(2,13) = 0.07, P = 
0.94 (see Figure 21). 
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Figure 20. The means for behaviors performed by adults tested immediately 
following treatment during the FST, A. immobility, B. swimming, and C. 
climbing. Error bars represent the SEM. 
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Figure 21. The means for behaviors performed by adults tested three weeks after 
treatment in the FST, A. immobility, B. swimming, and C. climbing. Error bars 
represent the SEM. 
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Corticosterone levels after the Forced Swim Test 
For adolescent treated rats, there was a significant time point by treatment by time of 
testing interaction on corticosterone levels, F(4,60) = 3.54, p = 0.01. This was followed up with 
repeated measures ANOVAs of corticosterone concentrations at the three measured time points 
after the FST for each time of testing group. For the rats treated in adolescence and tested 
immediately the interaction between time point and treatment was significant, F(4,34) = 5.82, P 
= 0.001. This was followed up with univariate ANOVAs of corticosterone concentration at each 
time point. Post hoc analyses indicated that at the zero time point, the corticosterone group had 
lower corticosterone levels than the ethanol group, p = 0.06, and the corticosterone group had 
lower levels than the water group, p < 0.001. At the zero time point the ethanol group had lower 
levels than the water group, p = 0.001. At 45 minutes after the test among the rats treated in 
adolescence and tested immediately corticosterone treated rats had lower levels than both the 
water and ethanol groups, p < 0.001, and ethanol and water groups did not significantly differ 
from one another (see Figure 22). For rats treated in adolescence and tested immediately, at 90 
minutes after the FST, the corticosterone group had lower levels than the ethanol group, p = 0.03 
(see Figure 22). 
F or the rats treated in adolescence and tested several weeks later, there was no treatment 
effect. The corticosterone levels decreased with time after the FST, F(2,26) = 31.30, P < 0.001 
(see Figure 22). 
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Figure 22. The means for the plasma concentrations of corticosterone experienced after the 
FST for those adolescent treated rats tested A. for immediate effects and B. for enduring 
effects. Error bars represent the SEM. * Indicates significantly different from the water group 
at that time point, p = 0.03 or less. 
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For adults there was a significant time point by treatment by time of testing" interaction on 
-corticosterone levels, F(4,56) = 5.35, P = 0.001. This was followed up with repeated measures 
ANOVAs of corticosterone concentrations at the three measured time points after the FST for 
each time of testing group. For the rats treated as adults and tested immediately, the interaction 
between time point and treatment was significant, F(4,30) = 13.92, p < 0.001. This was followed 
up with ANOVAs of corticosterone concentration at each time point. Post hoc analyses showed 
that at the zero time point, immediately after removal from the FST, the corticosterone group had 
lower corticosterone levels than the ethanol group, p < 0.001, and the corticosterone group had 
lower levels than the plain water group, p < 0.001. The ethanol group also had higher levels than 
the plain water group p = 0.03. At 45 minutes after the FST the corticosterone group had 
significantly lower levels of corticosterone than the water group, and the water group had 
significantly lower levels than the ethanol group, p < 0.001 for each comparison. For the adult 
treated rats tested immediately at 90 minutes after the FST the corticosterone group had lower 
levels of corticosterone than the water group, p = 0.02, and no other groups differed from one 
another (see Figure 27). For the rats treated as adults and tested several weeks later there was a 
significant effect of time point, F(2,26) = 46.90, p < 0.001, such that corticosterone levels 
decrease with time after the FST, but there was no effect of treatment (see Figure 23). 
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Baseline Corticosterone 
For the adolescent treated rats tested either immediately or several weeks later, there was 
no effect of treatment on baseline corticosterone, F(2,15) = 1.88, p = 0.19 for immediately tested 
and F(2,13) = 2.35, P = 0.13 for those tested several weeks later (see Figure 22). For the adult 
treated rats there was no effect of treatment, F(2,17) = 0.05, P = 0.95 for those tested 
immediately and F(2,13) = 0.40, p = 0.68 for those tested several weeks later (see Figure 23). 
Discussion for Experiment 2 
The main findings from Experiment 2 were that despite demonstrating effects on weight, 
corticosterone treatment was not sufficient to produce effects on the behavior of either adult or 
adolescent treated rats regardless of whether the rats were tested soon after treatment or weeks 
later. Corticosterone treatment was sufficient to dampen the HPA response to a novel stressor 
when tested soon after treatment regardless of the age at which treatment was administered. 
However, there were no effects of corticosterone treatment on HPA response when tested weeks 
after treatment regardless of the age at which treatment occurred. 
Weight 
Corticosterone treatment inhibited weight gain when administered either in adolescence 
or in adulthood. In both cases, corticosterone treated rats continued to weigh less than those 
without corticosterone one week after the period of administration was over, but after two weeks 
there were no differences in weight. For rats treated in adolescence ethanol treatment also 
decreased weight. Because ethanol has more calories than regular water, this decrease in weight 
was the opposite effect than expected. This effect on weight may be an indication that drinking 
ethanol is aversive for adolescents; it has been shown that adolescents mount a corticosterone 
response to ethanol exposure and that response is greater in adolescents than in adults (Silveri & 
Spear, 2004). As discussed previously, corticosterone has been shown to decrease weight; 
therefore the effect of ethanol on weight may be the result of a corticosterone response to ethanol 
consumption. That this effect is observed in the adolescents but not the adults may be the result 
of different responses to ethanol at differing ages, or it may be that the smaller dose ingested by 
the adults was insufficient to produce a weight difference. 
All groups recovered from the effects of corticosterone treatment such that their weight 
- was not different from untreated rats of the corresponding age group two weeks after the end of 
treatment, which suggests that this method of administration is not as potent as injection, for 
which weight differences persisted for three weeks. In those rats that received injections the 
weight differences were maintained for at least three weeks, despite the fact that the injected 
dose was lower than the doses ingested by rats administered corticosterone in their drinking 
water. The injected dose used in Experiment 1 has been shown to produce levels of 
corticosterone at about 2100 ng / mL for up to four hours after injection and decreased to around 
450 ng / mL by the next day (Sousa et aI., 1998), and the concentration of corticosterone given in 
the drinking water here, 400 J.1g / mL, has been shown to maintain a consistent plasma 
concentration of corticosterone at around 200 ng / mL, which was shown to be significantly 
increased from basal levels of vehicle treated controls (Magarinos et aI., 1998). Therefore despite 
the fact that the rats are taking in a greater dose of corticosterone, the effect is a much lower 
plasma concentration though it is maintained as consistently higher than vehicle treated controls. 
The difference in plasma concentrations may be due to different rates of absorption from a 
subcutaneous injection as compared to ingestion, the former getting absorbed into the 
bloodstream underneath the skin and the latter from the gut, or possibly the rate of intake is the 
key factor. Inj ected corticosterone is delivered once a day, but corticosterone administered in the 
drinking water is delivered to the animal several times a day. 
Intake and Doses 
The rats that were treated only with ethanol in their drinking water ingested a similar 
dose of ethanol to the corticosterone and ethanol treated group of corresponding age. However 
the ethanol treated groups are not good control groups to use for the purpose· of interpreting the 
effects of corticosterone treatment because the effects of ethanol on weight indicate that ethanol 
-consumption may be aversive, in that it altered physiology and metabolism. Therefore it is 
important to consider the comparison both to the ethanol treated rats and the rats that received 
plain water. The adolescent treated groups ingested a higher dose of both ethanol and 
corticosterone at the beginning of the period of administration. This difference is mainly the 
result of their weight, rats were consuming roughly the same amount of ethanol and 
corticosterone throughout the period of administration but the adolescence started out at a much 
lower weight. 
Depressive Behavior 
Neither corticosterone nor ethanol had any effect on depressive behavior in the FST 
regardless of the age at which the rats were treated or the time at which they were subsequently 
tested. The duration of treatment for Experiment 2 was the same as it was in Experiment I, and 
therefore may simply be insufficient to produce an effect of corticosterone in the FST, as 
discussed previously (reviewed in Sterner & Kalynchuk, 2010). However, unlike in Experiment 
1, the control groups here are completely without stressor experience. They were not even 
handled outside of regular cage cleanings during the period of administration. The rats during 
this experiment were also exposed to more corticosterone over the course of treatment, but this 
exposure was a little at a time. By administering corticosterone in the drinking water the control 
over the rate of administration is given to the rat. Therefore it is unlikely any of these rats 
ingested enough of their drinking water to get a very high dose of corticosterone at one instance. 
Corticosterone administered in drinking water has been shown to have varying effects on 
basal corticosterone levels such that it increased basal corticosterone when measured 
immediately after treatment (Magarinos et aI., 1998), but not when measured two weeks later 
'JL 
(Gourley & Taylor, 2009). In general administration methods such as corticosterone dissolved in 
- drinking water or implanted corticosterone pellets or pumps have been shown to have a smaller 
effect on the plasma concentrations of corticosterone than injections (reviewed in Sterner & 
Kalynchuk, 2010). These administration methods expose the rats to a constant but small 
elevation in corticosterone, which is not a good representation of what a rat undergoing chronic 
stress would experience. Acute stressors induce a large release of corticosterone that is brief in 
duration because negative feedback will quickly slow down its release. Even when stressors are 
presented chronically they involve a rise in corticosterone with a subsequent return to baseline. 
Therefore administering corticosterone in drinking water is not a good model for understanding 
the effects of stress that are the result of corticosterone exposure. 
Adolescent treated rats that were tested several weeks after treatment spent more time 
immobile, less time swimming or climbing and had a lower latency to become immobile than 
those adolescent treated rats that were tested immediately after treatment regardless of treatment 
group. Because these rats demonstrated no effect of treatment on behavior at either one of the 
times for testing, these differences are likely indicative of an age effect. The rats treated in 
adolescence and tested immediately after treatment were tested during adolescence, postnatal day 
47, but those tested several weeks after treatment were tested during adulthood, postnatal day 71. 
Therefore these results indicate that adult rats in general have a higher level of depressive 
behavior on the FST. The same effect was observed in Experiment 1 as well; the rats tested 
several weeks after treatment spent more time immobile than those tested immediately after 
treatment. This finding is consistent with other studies that have shown adolescents to spend less 
time immobile than adults (Hefner & Holmes, 2007; Pechnick et aI., 2008). These findings 
demonstrate the importance of including age matched controls when studying the effects of 
-exposure to stress or corticosterone during adolescence. 
HPA Response to a Stressor for Adolescent Treated Rats 
As predicted, the corticosterone treated rats tested immediately after treatment produced a 
smaller HPA response to a stressor, lower corticosterone concentrations after the FST, than those 
treated with ethanol or water regardless of the age at which the treatment was administered, 
similar to the results observed in Experiment 1. Additionally, rats treated with ethanol during 
adolescence and tested immediately after treatment produced a smaller initial corticosterone 
release after the FST than those treated with plain water. However, adult rats treated with ethanol 
and tested immediately after treatment displayed enhanced corticosterone response to the FST as 
compared to those treated with plain water. Additionally, for the rats treated at either age and 
tested several weeks after treatment, treatment produced no effect on HPA response to a stressor. 
As in Experiment 1, when rats were tested immediately after treatment the corticosterone 
response to a stressor was dampened. This is likely the result of the ongoing negative feedback 
produced by exposure to exogenous corticosterone. These results are consistent with other 
studies that have found the HPA response dampened when measured immediately after 
corticosterone treatment both when administration is given by injection (Johnson et aI., 2006) 
and by dissolving corticosterone in the drinking water (Pung et aI., 2003; Gourley & Taylor, 
2009). This indicates that corticosterone treatment in the drinking water is sufficient to activate 
negative feedback decreasing the production of corticosterone in the adrenal gland for some time 
after its removal from the drinking water. 
Because ethanol treatment during adolescence had a dampening effect on the HPA 
response to a stressor, administration of corticosterone when dissolved with ethanol in the 
drinking water is not well suited for studies involving adolescents. Chronic exposure to ethanol 
-can increase basal concentrations of corticosterone, but this result was found using a higher 
concentration of ethanol, 5%, than that used in this experiment, 2.5%, and a longer duration, 28 
days, than that used here, 16 days (Rasmussen et at, 2000). Other studies have shown that 
chronic exposure to ethanol can blunt the HPA response to stress in adults both with humans and 
rodents (reviewed in Prendergast & Little, 2007). Therefore these results are consistent with that 
literature, and indicate that a relatively low dose of ethanol is required to blunt the HPA response 
to a stressor when the ethanol is provided during adolescence. It has also been observed that 
ethanol exposure induces an increase in the plasma concentration of corticosterone (Silveri & 
Spear, 2004), and therefore the effects of ethanol exposure observed here may be the result of 
exposure to corticosterone. 
However ethanol treatment during adulthood had the opposite effect of ethanol treatment 
during adolescence on the HPA response to a stressor. This may be the result of a difference the 
effects of ethanol on a developing system compared to a mature system. However, it must also be 
considered that the adolescents consumed a larger dose of ethanol, and therefore it is unclear 
whether the discrepancy between the effects of treatment at these ages is the result of the 
difference in dose or age. Other studies have shown a blunted HPA response after chronic 
exposure to ethanol (reviewed in Prendergast & Little, 2007), and that ethanol can increase basal 
corticosterone concentrations (Rasmussen et aI., 2000). However, as mentioned previously these 
studies use larger concentrations and longer durations of administration, therefore the 
discrepancy may be the result of these differences in exposure. Additionally one study has 
observed that with early adolescents, postnatal day 34 and young adults, postnatal day 60, six 
exposures to a small dose of corticosterone (2.2-2.6 g/kg) can increase the corticosterone 
response to swim stress (Silveri & Spear, 2004). The dose used in that study is closest to the dose 
- ingested by the adults, and the effect is opposite what is observed in studies using larger doses 
(Rasmussen et aI., 2000), therefore it may be that dose and not age is the relevant factor. 
Therefore it is plausible that a shorter duration and lower dose when administered during 
adulthood may produce an increase in corticosterone response to stressors. 
The lack of an enduring effect of corticosterone on HPA response may be the result of the 
nature of administration and its inability to sufficiently activate GRs. Corticosterone 
administration that does not produce a very high plasma concentration of corticosterone, such as 
administration in drinking water, may not be able to activate many glucocorticoid receptors 
(GRs). Because mineralocorticoid receptors (MRs) have a higher affinity for corticosterone, at 
low concentrations of corticosterone most MRs are occupied (89.5%) and few GRs are (15%) 
(Reul & de Kloet, 1985; Spencer et aI., 1990). Therefore administering corticosterone in the 
drinking water is likely to increase MR activation, but not likely to have much of an effect on GR 
activation. Because MRs are activated at basal concentrations of corticosterone and GRs are 
activated after high concentrations of corticosterone, such as those experienced after a stressor, it 
is thought that the effects of stress that are corticosterone related are the result of the activation of 
GRs (reviewed in de Kloet et aI., 1998). In Experiment 1 corticosterone treatment by injection 
during adolescence produced an increased HPA response when tested several weeks after 
treatment, and here there was no effect of treatment despite the fact that the rats were ingesting 
larger doses of corticosterone over the same period of time at the same ages. The most likely 
explanation for this discrepancy is that exposure to a sufficiently high concentration of 
corticosterone that adequately activates GRs is required to produce enduring effects on the HPA 
response. 
General Discussion 
The most definitive conclusion that can be drawn from these two experiments is that 
when studying adolescents one needs to consider carefully the effects of every manipulation and 
carefully design control groups to account for possible confounds. Corticosterone displayed no 
effects on depressive or anxiety-like behavior regardless of age at which the treatment was 
administered, time at which the rats were tested, or method of administration used. Exposure to 
exogenous corticosterone administered during adolescence had an enduring effect to increase the 
HPA response to a stressor when administered by injections, but not when administered in the 
drinking water and not when administered in adulthood. Exposure to ethanol during either 
adulthood or adolescence can affect the HPA axis. In adolescence ethanol dampened the HPA 
response to a stressor, and in adulthood ethanol increased the HPA response to a stressor. 
However, the adolescents ingested a higher dose of ethanol during the majority of the 
administration period; therefore it remains unclear whether the different effects are a result of 
age differences or dose differences. 
The fact that ethanol can affect the HPA demonstrates that administration of 
corticosterone with ethanol dissolved in drinking water is a poor model for studying the effects 
of corticosterone on the HPA, because the effects of ethanol and corticosterone are not easily 
distinguished. However administering corticosterone by injections involve a stressor to which 
adolescents may be uniquely sensitive, and therefore corticosterone injections are a poor model 
to use when studying adolescents. A better way to study the effects of corticosterone exposure 
during adolescence may he to induce endogenous release of corticosterone with a stressor. 
It is also important to consider that the stress response is much more complex than the 
eventual release of corticosterone from the adrenal gland. Corticosterone release is only one step 
':)1 
in the response of the HPA axis to a stressor; the hypothalamus becomes activated"and releases 
- both corticotrophin releasing hormone and arginine vasopressin and the pituitary will release 
adrenocorticotropic hormone which in tum signals the adrenals to release corticosterone 
(reviewed in Herman & Cullinan, 1997). When a stressor is experienced all of these hormones 
are released and have their own unique effects on the brain and body. In addition to the HPA axis 
other systems also respond to stressors, for example the noradrenergic system releases 
catecholamines in response to a stressor to increase arousal (Morilak et aI., 2005). Endogenous 
opiates are also released in response to a stressor, which can induce analgesia (reviewed in 
McEwen & Sapolsky, 1995). The response to a stressor involves much more than corticosterone 
release, and therefore experiments that examine the effects of corticosterone administration, such 
as those described in this thesis, only account for one facet of the stress response. 
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In the MANOVA for time in the open arm, ratio of open arm to total arm entries, time in 
the center, closed arm entries, head dips, rears and latency to the open arm with treatment and 
time of testing as the between subjects factors for adolescents there was no effect of treatment on 
time in the open arm, F(1,46)=0.03, p=0.86, ratio of open arm to total arm entries, F(1,46)=3.SS, 
p=0.07, time in the center, F(1,46)=0.01, p=0.93, closed arm entries, F(1,46)=1.49, p=0.23, head 
dips, 0.77, p=0.39, rears, F(1,46)=0.78, p=0.38, or latency to the open arm, F(1,46)=0.OS, 
p=0.83. 
A MANOVA for time in the open arm, ratio of open arm to total arm entries, time in the 
center, closed arm entries, head dips, rears and latency to the open arm with treatment and time 
of testing as the between subj ects factors showed that adults had no effect of treatment on time in 
the open arm, F(1,49)=0.94, p=0.34, ratio of open arm to total arm entries, F(1,49)=1.92, p=0.17, 
time in the center, F(1,49)= 0.03, p=0.87, closed arm entries, F(1,49)= 0.002, p=0.96, head dips, 
F(1,49)=3.64, p=0.06, rears, F(1,49)=1.30, p=0.26, or latency to the open arm, F(1,49)=1.19, 
p=0.28. There was no effect of time of testing on time in the open arm, F(1,49)=3.S1, p=0.07, 
ratio of open arm to total arm entries, F(1,49)=0.29, p=0.S9, time in the center, F(1,49)=2.S4, 
p=0.12, closed arm entries, F(1,49)=0.93, p=0.34, rears, F(1,49)=0.28, p=0.60 and latency to the 
open arm, F(1,49)=0.48, p=0.49. 
llL. 
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Experiment 2 
-FST 
Latency to immobility: For adolescents there was a significant effect of time of testing on 
latency to immobility, such that the rats tested for enduring effects took less time to become 
immobile than the adolescents tested immediately following treatment, F(I,30)=22.94, p<O.OOO, 
but not for adults, F(I,30)=0.97, p=0.33. 
Climbing: For the adolescents there was a significant interaction between time of testing 
and time point in the test, F(3,90)=7.43, p<O.OOO, and the same was true for the adults F(3,90) 
=4.74, p=O.004. There was also a main effect of time point such that the rats climbed less and 
less throughout the test, F(3,90)=197.96, p<O.OOO. 
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